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Patellar tendinosis is a common disorder causing longstanding pain, stiffness and 
dysfunction of the patellar tendon. It mainly affects recreational athletes, manual 
workers but also sedentary patients. At present, there is no effective treatment and is 
therefore one of the most challenging clinical problems facing the orthopaedic 
surgeons. Histopathologic studies on patellar tendinosis demonstrate major 
disorganization and loosening of collagen fibrils. Other obvious alterations in 
tendinosis include hypercellularity, hypervascularity and increase in 
glycosaminoglycans content. 
This study aims to characterize the fibroblasts derived from patellar tendinosis tissues 
and the factors secreted in patellar tendinosis fibroblasts. Angiogenic ability and 
proteolytic ability of the factors secreted in tendinosis fibroblasts were examined. 
Inflammatory response and possible growth factors secreted in tendinosis fibroblasts 
were also characterized. 
Primary explant cell culture was used to derive the fibroblasts from the patellar 
tendinosis tissues. Immunocytochemical staining was used to verify that the cell 
derived from patellar tendinosis tissues were fibroblastic in nature. The proliferation 
of fibroblasts was assessed with the stimulation of F B S and PDGFBB. The expression 
of PDGFp receptor was examined by immunocytochemical staining. 
V 
ABSTRACT 
The factors secreted in tendinosis fibroblasts were characterized for its angiogenic 
ability. The angiogenic effect of the secreted factors on ECV304 endothelial cells was 
assessed by BrdU incorporation assay. Chemostatic response of endothelial cells on 
the factors secreted in tendinosis fibroblasts was assessed by invasion assay whereas 
its in vivo angiogenic ability was assessed by chick chorioallantoic membrane (CAM) 
assay. 
The proteins secreted in tendinosis fibroblasts were separated by SDS-PAGE. The 
possible growth factors present in the conditioned media were identified and quantify 
using enzyme-linked immunosorbent assay (ELISA). 
Proteolytic activities of the factors secreted in tendinosis fibroblasts were studied 
using gelatin zymography. The amount ofMMP-1 and TIMP-1 secretion in tendinosis 
fibroblasts was quantitated by MMP-1 and TIMP-1 ELISA. For the identification of 
inflammatory factors secreted in tendinosis fibroblasts, the level of PGE2 was 
quantitated by PGE2 ELISA and the expression of COX-2 was studied using 
immunocytochemical staining. 
Results from in vitro characterization of tendinosis fibroblasts showed that tendinosis 
fibroblasts were more proliferative and expression of PDGFp receptor was elevated. 
The up-regulated expression of PDGFp receptor in tendinosis fibroblasts caused more 
sensitive to stimulation, including F B S and PDGFBB. The hypercellularity is likely to 




The factors secreted in tendinosis fibroblasts enhance endothelial cells proliferation 
and chemotactic to human ECV304 endothelial cells when compared with the healthy 
control. Besides, it also enhanced blood vessel formation in CAM assay. 
Hypervascularity found in patellar tendinosis tissues is likely related to the angiogenic 
factors secreted in tendinosis fibroblasts. 
Result from gelatin zymography showed that tendinosis fibroblasts secreted more 
proteolytic enzymes. Quantitation of MMP-1 and TIMP-1 showed that tendinosis 
fibroblasts secreted more MMP-1 but less TIMP-1 when compared with healthy 
control. The increased matrix degradation in tendinosis tissue is likely associated with 
the abnormal MMP-1 and TIMP-1 secretion. Besides, tendinosis fibroblasts secreted 
more PGE2 and the expression of COX-2 was also elevated in tendinosis fibroblasts. 
Secretion of TGFpi and P D G F B B were higher in tendinosis fibroblasts. TGFpi is 
mitogenic to fibroblasts and capable to increase MMP-1 and COX-2 secretion. 
P D G F B B is a well-known mitogenic factor and also capable to induce angiogenesis. 
In conclusion, cellular activities of tendinosis fibroblasts are higher than healthy 
control. The typical characteristics of patellar tendinosis including hypercellularity, 
hypervascularity, matrix degradation and symptom of pain are likely associated with 




Future research direction in the study of alteration of patellar tendinosis should be 
focused on the further characterization of the growth factors pathway in patellar 
tendinosis. Besides, establishment of an animal model and clinical study are also 
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"Tendinosis" is a clinically defined as chronic tendon disorder with unknown 
etiology. The clinical manifestation is longstanding localized activity related pain, 
stiffness and dysfunction. There is no defined and consistent rationale in the 
current management as unknown pathogenesis and etiology. 
Histopathological investigations on patellar tendinosis tissues consistently 
demonstrate the hypercellularity, hypervascularity, disruption of extracellular 
matrix, loosening of collagen fibrils and lack of inflammatory cells infiltrates. 
However, the etiology and pathogenesis of patellar tendinosis is still unknown. 
In this study, explant cell culture technique was used to derive the fibroblasts from 
the tissues in order to study the pathological changes of tendinosis fibroblasts. 





Where are the tendinosis tissues and healthy control specimens  
come from? 
] r  
Answer: 
• With the recruitment criteria, all the tendinosis specimens were 
taken from the patients in the surgical treatment. 
•=> The healthy control were taken from the patients who underwent 
the ACL reconstruction, using the patellar tendon as autograft 
] r  
Question 2: 
How to obtain the fibroblasts from the tendinosis and healthy 
specimens? 
1 r  
Method and Answer: 
^ Primary explant culture technique was used to derive the 
fibroblasts from the specimens. 
] r  
Question 3: 
How to confirm the cells derived from the tissues are  
fibroblasts? 
] r  
Method and Answer: 
•=> Immunocytochemical staining of fibroblasts confirm the cells 
derived are fibroblasts 
xviii 
His her Proliferation Potential of Tendinosis Fibroblasts 
Question 4: 
Is the hypercellularity found in tendinosis tissues related to the  
proliferation capacity of tendinosis fibroblasts? 
] r  
Methods: 
• Using BrdU incorporation assay to assess the proliferation rate of  
tendinosis fibroblasts under FBS supplementation. 
Answer: 
•=> Tendinosis fibroblasts have higher proliferation potential than 
healthy tendon fibroblasts under the same cell culture condition 
] r  
Question 5: 
Is the PDGFBB, a mitogen for fibroblasts, contribute the higher  
proliferation capacity in tendinosis fibroblasts? 
] r  
Methods: 
BrdU incorporation assay for proliferation measurement. 
•=> Immunocytochemical staining of PDGFp receptors. 
Answer: 
• Higher proliferation found in the tendinosis fibroblasts culture 
with lOng/ml PDGFBB supplementation. 
• Immunocytochemical staining of PDGFp receptors showed 
higher expression of PDGFP receptors in tendinosis fibroblasts. 
Publication: Paper 1 
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Question 6 
xviii 
Collection of Conditioned Medium 
Question 6: 
How to collect the conditioned medium from the fibroblast  
culture? 
^ r  
Method and Answer: 
According to the Descalzi et al 1995. The serum free DMEM was 
incubated in the culture flask for 24 hours. 
O The conditioned medium was stored under -80°C 
] r  
Question 7: 
How to measure the protein content in the conditioned medium? 
Any different of protein content in tendinosis conditioned 
medium? 
y_  
Method and Answer: 
• Bradford protein assay was used to assessed the protein content in 
the conditioned medium 
• There is no different between the amount of protein secreted, 
y  
Characterization of Factors Secreted in Tendinosis Fibroblasts 
xviii 
Characterization of Factors Secreted in Tendinosis Fibroblats - Mitosenic Effect 
Question 8: 
Do the factors secreted in tendinosis fibroblasts mitogenic? 
\ r  
Methods: 
•=> Tendinosis conditioned medium was used to supplement with 
tendon fibroblasts 
•=> BrdU assay was used to assess the proliferation. 
Answer: 
• Supplementation of tendinosis conditioned medium promote 
higher proliferation in tendinosis and healthy tendon fibroblasts. 
y 
Contribution from Q4, 5 and 8: 
•=> Hypercellularity in tendinosis is likely associated with the 
hyperproliferative nature of tendinosis fibroblasts. 
• Tendinosis fibroblasts secrete mitogenic factor which 
promote the proliferation of tendon fibroblasts. It further 
promote the proliferation of tendinosis fibroblasts. 
Characterization of Factors Secreted in Tendinosis Fibroblasts — Angiogenic Effect 
Question 9: 
Does the factors secreted in tendinosis fibroblasts angiogenic? 
] r  
Methods: 
•=> Tendinosis conditioned medium was used to supplement the 
endothelial cells. 
'=> BrdU assay was used to assess the proliferation. 
Answer: 
•=> Supplementation of tendinosis conditioned medium promote 
higher proliferation in human endothelial cells. 
] r  
Question 10: 
•=> Is the factor(s) secreted in tendinosis fibroblasts  
chemotactic to endothelial cell? 
] r  
Methods: 
Invasion assay was used to assess the chemotactic response of 
endothelial cells to the factors secreted. 
Answer: 
The factor chemotactic to endothelial cells 
1 r  
Question 11: 




• CAM model was used to assess the in vivo angiogenesis of the 
factors secreted in tendinosis fibroblasts. 
Answer: 
^ The factors secreted enhance angiogenesis in CAM model 
Publication: Paper 4 
xviii 
Characterization of Factors Secreted in Tendinosis Fibroblasts - Proteolytic 
Activity 
Question 12: 
Does the tendinosis fibroblasts secrete proteolytic enzyme? 
I f  
Methods: 
^ Gelatin zymography was used to assess the proteolytic activity of 
the factors secreted in tendinosis fibroblasts. 
Answer: 
•=> Tendinosis fibroblasts secrete more proteolytic activity 
Publication: Paper 2 
• 
Question 13: 
•=> Is there any imbalance of MMP-1 and TMP-l in secretion  
of tendinosis fibroblasts? 
y 
Methods: 
• MMP-1 and TMP-l ELISA were used to quantitate the amount  
of MMP-1 and TIMP-1 in conditioned media 
Answer: 
• MMP-1 secretion in tendinosis was elevated but decrease TIMP-1 
secretion. 
Publication: Paper 2 
] r  
Contribution: 
•=> Matrix disruption in tendinosis is likely associated with the 
imbalance of MMP-1 and TIMP-1 secretion. 
xviii 
Characterization of Factors Secreted in Tendinosis Fibroblasts 一 Inflammation 
Response 
Question 14: 
Does the tendinosis fibroblasts showed any inflammatory 
response? 
1 r  
Methods: 
•=> PGE2 ELISA was used to quantitate the amount of PGE2 in 
conditioned medium 
Immunocytochemical staining of COX-2 in tendinosis 
fibroblasts. 
Answer: 
• Tendinosis fibroblasts secrete more PGE2. 
• Expression of COX-2 in tendinosis fibroblasts was higher. 
• 
Contribution: 
•=> The symptom of pain is likely associated with the PGE2 
and COX-2. 
• Proinflammatory response was found in tendinosis 
fibroblasts. 
1 r 
Characterization of possible growth factors secreted by tendinosis 
fibroblasts. 
xviii 
Characterization of the Factors Secreted in Tendinosis Fibroblasts 
Question 15: 
How to analyze the protein contained in conditioned media? 
y r  
Method: 
• SDS-PAGE electrophoresis to separate the proteins in conditioned 
medium 
Answer: 




How to quantitate those factors secreted in tendinosis 
1 r 
Method: 
• TGF-pi and PDGFBB E L I S A were used to quantitate the amount  
in conditioned medium. 
Answer: 
• Tendinosis fibroblasts secrete more TGF-pi and PDGFBB. 
Y  
Contribution: 
The characteristics of tendinosis tissues including 
hypercellularity, hypervascularity and extracellular matrix 
degradation are likely associated with the abnormal growth 
factors secretion in tendinosis fibroblasts. 
xviii 
Conclusion 
Question 1 to 16 
1 r 
Conclusion: 
In conclusion, the cellular activities of tendinosis fibroblasts are actually higher 
than normal tissue. The typical characteristics of tendinosis including 
hypercellularity, hypervascularity, matrix degradation and symptom of pain are 
likely to be associated with the elevated secretion of inflammatory factors and 
growth factors, including TGF -p i and PDGFBB. 
• 
Future Direction: 
Study of alteration of tendinosis should be focused on the further 
characterization of the growth factors pathway in tendinosis. 
Establishment of an animal model and clinical study are also important for 
the therapeutic treatment and understanding the pathogenesis of tendinosis. 
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CHAPTER ONE INTRODUCTION 
1.1 BASIC STRUCTURE OF TENDONS 
Tendons are anatomical structures interposed between muscles and bones that 
transmit the force created within muscle to bone, making joint movement possible. 
The basic elements of tendon are collagen bundles, cells and ground substance 
(extracellular matrix), a viscous substance rich in proteoglycans. Collagen provides 
tendon with tensile strength whereas ground substance provides structural support for 
the collagen fibres and regulates the extracellular assembly of procollagen into mature 
collagen (Figure 1.1). Tendon fibroblast, which is a flat, tapered cells sparingly 
distributed among collagen fibrils, synthesize both ground substance and protein 
procollagen building blocks. Collagen is hierarchically arranged in levels of 
increasing complexity, beginning with tropocollagen, fibres, fasciles, tertiary bundles 
and finally, the tendon itself. 
L1.1 Macroscopic Structure 
Then tendon is entirely covered by the epitenon, which is a fine, loose connective 
tissue sheath containing the vascular, lympathatic and nerve supplies. The epitenon 
extends deeper into the tendon between the tertiary bundles as the endotendon. More 
superficially, the epitenon is arrounded by paratenon, a loose aureolar connective 
tissue consisting essentially oft>pe I and type III collagen fibrils, some elastic fibrils 
and an inner lining of synovial cells. Together, the paratenon and epitenon are 
sometimes called the peri tendon (Figure 1.1) 
34 
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The classic 2-layered synovial tendon sheath is only present in certain tendons at areas 
of increased mechanical stress. The outer layer of the sheath is the fibrotic sheath and 
the inner layer is the synovial sheath which consists of thin visceral and parietal sheets. 
The myotendinous junction is a highly specialized anatomical region of the 
muscle-tendon unit where tension generated by muscle fibres is transmitted from 
intracellular contractile proteins to extracellular connective tissue proteins. 
L1,2 Microscopic Structure 
Healthy tendon consists of dense, clearly defined, parallel and slightly wavy collagen 
bundles. Also，collagen has a characteristic reflective appearance under polarized 
microscopy. Between the collagen bundles there is a fairly even, sparse distribution of 
cells with thin, wavy nuclei. Tendon is supplied by a network of small arteries 
oriented parallel to the collagen fibres in the endotendon (Jozsa, 1997; Astrom, 1987; 
Khan, 1996). 
The tendon cells, or the tenoblasts and tenocytes comprise about 90% to 95% of the 
cellular elements of the tendon (Jozsa, 1997). The remainders, including the 
chondrocytes at the pressure and insertion sites, the synovial cells of the tendon sheath 
on the tendon surface, and the vascular cells, such as capillary endothelial cells and 
smooth muscle cells of the arterioles in the endotendon and epitenon, are less than 5% 
to 10% in the normal tendon. 
4 
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The cell-to-matrix ratio gradually decreases with aging, and also many other changes 
occur inside the tendon cells. The newborn tendon has a very high cell to matrix ratio, 
the tenoblasts have different shapes and sizes. In young individuals, a gradual 
decrease in the cell-to matrix ratio occurs and the tenoblasts start to resemble each 
other and are spindle shaped. In adults, the cell-to-matrix ratio further decreases and 
the nucleus-to-cytoplasm ratio increases, the tenocytes become very flat and 
elongated. Tenocytes sparingly distribute among collagen fibrils, synthesize both 
ground substance (proteoglycans) and collagen 
1.1.3 Extracellular Matrix 
The extracellular matrix in tendon is synthesized by tenocytes. The extracellular 
matrix of tendons can be classified into three groups: collagen, elastin fibers and the 
ground substance, mainly the proteoglycan and the inorganic components. Collagen is 
the main structural protein in extremity tendon where comprises 65-80% of the dry 
weight. The proteoglycans and glycoproteins account for less than 2% of the total dry 
weight of the tendon. The content of water is 60-80% of the total weight of tendons. 
1.1.3.1 Collagen 
Collagen is not just one protein, more than 20 different types of collagen molecules 
have been found and they can be divided into fibrillar and nonfibrillar collagens on 
basis of the supramolecular structures. The structural unit of collagen is tropocollagen, 
a long, thin protein 200mn long and l.Srnn wide, which consists mainly of type 1 
5 
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collagen. It is formed in the fibroblast cell as procollagen and consist of three 
polypeptide chains (alpha units) wound together to form a ropelike triple helix 
(obrien). The chains are rich in glycine and proline. It also contains two amino acids, 
not often found in other proteins, hydroxyproline and hydroxylysine. Tropocollagen 
molecules are stabilized and held together by electrostatic bond chemical 
cross-linking. Hydroxilysine containing cross-links are the most prevalent 
intermolecular cross-links in native insoluble collagen. Cross-links are important to 
the tensile strength of collagen to allow for increased energy absorption, and increase 
its resistance to proteases. Collagen type I，which is composed of two a l (I) chains 
and one a2 (I) chain, is the major collagen in the tendon (>95%). Collagen type III, 
which may increase when the tendon is healing, comprises less than 5% of the total 
collagen content in the healthy tendons. 
Matrix metalloproteinases (MMPs) are a family of enzymes whose responsible for the 
degradation of extracellular matrix. These enzymes are present in normal healthy 
individuals and have been shown to have an important role in processes such as 
wound healing, embryo implantation, morphogenesis, ovulation, cell migration, 
tissue involution, angiogenesis, tumor invasion and metastasis (DeClerk YA et al, 
1997). However, breakdown of extracellular matrix by MMPs is a key feature in 
certain disease, such as rheumatoid arthritis, periodontal disease and cancer. MMPs 
have been defined functionally as having the following characteristics: (1) they are 
proteinases that degrade at least one component of the extracellular matrix, (2) they 
contain a zinc ion and are inhibited by chelating agents, (3) they are secreted in a 
latent form, requiring activation for proteolytic activity, (4) they are inhibited by 
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Tissue Inhibitors of Metalloproteinases (TIMPs) and (5) they share common amino 
acid sequences. MMPs can be produced by stromal cells, glandular epithelial cells, 
haematopoetic cells in normal tissues. In some pathological condition, MMPs can 
also be produced by tumor cells and transforming cells. The substrate specificity of 
MMPs is not clear-cut. Several categories of MMPs can be identified according to 
their proteolytic activity, i.e. collagenases, stromeolysins and gelatinases. In fact all 
MMPs, except membrane type metalloproteinases, are secreted as inactive zymogens 
into extracellular matrix, where subsequent activation results in cleavage of the 
proenzymes into the active species. 
MMPl is a collagenase with substrate specific for type I, II，III VII, VIII and X 
collagen and gelatin. It is secreted from stimulated macrophages, neutrophils and 
transformed cells in a latent form (Woodhouse FC et al, 1997). MMPl is regulated 
through a corresponding set of TIMPs, such as TIMPl and TIMP2, which binds 
specifically to MMPl and render it inactive. TIMPs are known to inhibit invasion and 
metastasis in animal models, and hence, are capable of altering the metastatic 
potential of cancer cells. Remodeling of extracellular matrix in tendon is regulated 
through a balance between collagen synthesis and degradation. The balance between 
the level of active MMPs and available TIMPs determines the net MMPs activity and 
is therefore a pivotal determinant ofECM turnover. It also demonstrated to associate 
with collagen disturbances in tendons and ligament injuries. 
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1.1.3.2 Proteoglycan 
The glycosaminoglycans are linear polysaccharides that, with the exception of 
hyaluronic acid, are bound covalently to a protein core forming a proteoglycan. It has 
a great capacity absorbing water to resist shear and compression. There is small 
amount in tendons subjecting mainly to extension forces. The main proteoglycans in 
tendons are composed of a core protein associated with four main 
glycosaminoglycans, dermatan sulphate, chondroitin sulphate, keratan sulphate and 
heparin sulphate. The biological functions of proteoglycans are manifold. It can be 
essential for collagen matrix organization, shock absorber in cartilages by resisting 
compressive load and giving resilience to the these tissues. Some of the proteoglycan 
are structural components of basement membranes throughout the body and provide 
their surfaces with an array of negative charges that can act as an anti-thrombogenic 
barrier. 
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1.2 ANATOMY OF PATELLAR TENDON 
The patellar tendon, the extension of the common tendon of insertion of the 
quadriceps femoris muscle, takes its origin from the apex or distal pole of the patella 
and inserts distally into the tibial tuberosity (Figure 1.2). In adult it is about 2.5 to 4.0 
cm wide in the coronal plane and 4 to 5 mm deep in the sagittal plane. The average 
length of the patellar tendon is 4.3 to 4.6 cm. The course of the patellar tendon is 
somewhat oblique and narrows about 15% as it inserts into the tibial tubercle, 
although variable, is usually in 15° of external rotation on the anterior shaft of the tibia. 
The patellar tendon is primarily derived from the central fibers of the rectus femoris, 
which extend over the anterior surface of the patella. This condensation of fibers 
forms a flat tendinous structure that inserts into the tibial tubercle. As the tendon 
continues past the tubercle, it blends with the iliotibial band on the anterior surface of 
the tibia. 
The patellar tendon is surrounded by two layers tendon sheath. The outer layer is the 
fibrotic sheath and the inner layer is the synovial sheath. Their main function is to 
minimize the friction between the tendon and its surrounding structures. The 
prepatellar bursa lies just superficial to the patella and patellar tendon and provides a 
discrete layer (Jozsa, 1997). 
The blood supply to the patellar tendon arises from both extrinsic and intrinsic sources. 
The extrinsic source originates from a vascular anastomosis. The main contributors 
are the medial inferior genicular, lateral superior genicular, lateral inferior genicular, 
9 
n u n m one introdikiion 
and the anterior tibial recurrent artery (Scapinelli, 1997). The intrinsic source is 
actually an intratendinous supply. The infrapatellar fat pad has previously been 
suggested as a major blood source to the patella, but recent data refute this belief 
(Insall J.N, 1996). 
The neurologic input to the patellar tendon is formed by communications between the 
terminal branches of the lateral, intermediate, and medial cutaneous nerves of the 
thigh, as well as the infrapatellar branch of the saphenous nerve. The patellar tendon 
as part of the extensor mechanism of the knee contributes to stability and movement 
of the knee as well as the patellofemoral joint. 
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1.3 CELLULAR CHARACTERISTICS OF FIBROBLASTS 
The connective tissues cells in the tendon are mainly tendon fibroblasts. Fibroblasts 
appear to be least specialized cells in the connective tissue family (fibroblasts, 
cartilage cells, bone cells, fat cells and smooth muscle cells). They are responsible for 
the synthesis, assembly, deposition, and organization of extracellular matrix 
molecules including collagen and proteoglycans (Doane KJ et al, 1991). They are 
dispersed in connective tissue throughout the body, where they secrete a non-rigid 
extracellular matrix that is rich in type I and / or type HI collagen. 
When a tendon is injured, the fibroblasts nearby migrate into the wound, proliferate, 
and produce large amount of collagenous matrix, which helps to isolate and repair the 
damaged tissue. TGF-Ps are powerful regulators of growth, differentiation and matrix 
synthesis by fibroblasts, exerting a variety of actions depending on the target cell type 
and the combination of other factors and matrix components that are present. PDGFs 
are potent mitogen for the growth and matrix synthesis in fibroblasts. It is chemotactic 
for fibroblasts. Other reported activities for PDGFs include stimulation of collagen 
synthesis, collagenase activities and secretion. It is reported that many transformed 
cells and tumor cells express some form of PDGF in autocrine secretion. On the other 
hand, PDGFs certain plays a role in the normal process of wound healing. 
Tendon fibroblast culture is commonly used in the in vitro study of tendon and 
ligaments. Tendon fibroblast culture is generally used for testing the cellular 
characteristics towards the factors stimulation. Those studies include the effect of 
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growth factors on in vitro tendon healing model (Chan et al, 1997), the effect of 
ultrasound on the rate of collagen synthesis and cell proliferation (Ramirez A et al, 
1997) and the cellular responses of the fibroblasts after the chemical stimulation or 
drug treatments (Almekinders LC et al, 1995; Vogel KG et al, 1986; Bienkowski et al, 
1986; Stein LE 1985). In this study, we use tendon fibroblasts culture to characterize 
the fibroblasts derived from the tendinosis tissues and healthy patellar tendon 
fibroblasts were used as control. 
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1.4 HEALING PROCESS IN TENDONS 
J.3,1 Normal Healing Process 
Non-healing status has been regarded as a general feature in tendinosis (Leadbetter, 
1992; Astrom & Rausing, 1995) regardless of its cause. This hypothesis is based on 
the understanding towards normal healing process in tendons. When the tendon is 
injured, it undergoes a healing process: inflammation, proliferation and maturation 
(Figure 1.3). The first process encountered is inflammation. In the acute phase of 
inflammation, the release of vasoactive and chemotactic factors as well as the 
activation of the platelets and the coagulation system cause vasodilatation, increased 
vascular permeability, and the attraction of necessary inflammatory cells to the areas. 
The subsequent debridement process is mediated by neutrophils and macrophages. 
Proteases and collagenases related may be activated by plasminogen activators 
(Pepper MS et al, 1987). Extrinsic inflammatory cells secrete chemotactic, mitogenic 
and angiogenic factors, such as fibronectin and macrophage-derived growth factor, 
initiating subsequent healing stages in the injured tissue. A number of chemical 
mediators such as histamine and prostaglandin are also placed an important role in the 
acute phase of inflammation. Angiogenesis results in new capillary growth into the 
wound to increase nutrient supply for repair. Progression to chronic inflammation will 
occur when wound is contaminated with pathogens or when acute inflammatory 
response cannot remove the foreign material. The resultant pain, swelling, erythema, 
and increased warmth the clinical onset of the injury. Inflammation lasts two to five 
days and is followed by the proliferative phase and the phase of tissue maturation and 
13 
CHAPTER ONE INTRODUCTION 
remodeling. The inflammation may persist longer, becoming self-perpetuating and 
involve surrounding structures. In the second stage of healing, fibroblasts begin to 
produce collagen and matrix proteoglycans. In this phase, these products are 
immature and lack of organization and are therefore susceptible to destruction if 
further trauma or inflammation occurs. The restoration of matrix components 
parallels the increase in mechanical strength of injured soft tissue. Continuous 
deposition and degradation of collagen matrix persists for a long period of time for 
remodeling. Newly synthesized collagen type III may change to mature collagen type 
I as the tissue heals. Minor collagens, such as type XII regulates interaction of 
collagen fibrils with matrix proteoglycans, and may also be important in repair tissue 
maturation. In addition, other specific components of extracellular matrix such as 
tenascin, elastin, small proteoglycans, and fibronectin also participate in the healing 
process. During matrix maturation, collagen fibril diameter and the amount of 
cross-linking increase. They are associated with the reconstitution of the tensile 
strength of the tissue. Alignment of collagen fibrils along lines of mechanical strain 
occurs within the tissue through remodeling, a critical but poorly understood aspect of 
soft tissue healing. 
Cytokines Involved in Tendon Healing 
Cytokines originally referring to peptides involved in immunologic and hemapoietic 
regulation such as interleukines, colony stimulating factors, and interferons, 
functionally overlap with growth factors which stimulate proliferating and other 
cellular activities. In soft tissue healing, growth factors may play a role in the 
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inflammatory and regenerative phases of healing in that many of them have unique 
properties in (1) reducing inflammation，(2) minimizing scar tissue formation, (3) 
promoting functional restorations of the normal soft tissue (Henninger R, 1994). 
Then significance ofPDGF, IL-6, TGF-a and TGF-p in healing has been revealed by 
their presence in wound fluid following injury (Ono I et al, 1995). Similar to 
macrophages, platelets are also essential for healing as they secrete platelet-derived 
growth factor (PDGF) which is chemotactic, mitogenic and angiogeneic for a number 
of cells such as fibroblasts and endothelial cells. Apart from PDGF, TGFs are also 
able to stimulate endothelial cells migration and proliferation and therefore 
angiogenic. In this study, we are focusing on the P D G F B B and TGF-P secreted from 
tendon fibroblasts. 
1.3.2.1 Platelet Derived Growth Factor 
Platelets circulating in the peripheral blood derive from bone marrow megaryocytes. 
The functions of platelets are manifold. They contain and release several factors 
which include PDGF, INF-y, platelet-derived endothelial cell growth factor 
(PD-ECGF). PDGF is a potent mitogenic factor released by platelets and play a 
fundamental role in inflammation, neoplasia and embryogenesis and wound healing 
and in the complex processes associated with tissue repair following injury. PDGF is 
indispensable for the growth in vitro, and probably also in vivo, of cells derived from 
connective tissue. PDGF is the most potent mitogenic agent for cells of mesenchymal 
origin, including fibroblasts, vascular smooth-muscle cells and glial cells. 
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The molecule structure ofPDGF is composed of two disulphide-bonded polypeptide 
chains of about equal size, denoted A and B. Three forms ofPDGF have been shown 
to exist, P D G F A A , P D G F B B and PDGFAB- They bind with different affinities to two 
receptor types, the a - and the (3- receptor. PDGFRa binds both the A- and the B-chain 
while PDGFRP binds only the B-chain. Besides, P D G F B B can up-regulate PDGFRp 
and this phenomena is commonly found in pathological tissues. 
Early effects of PDGF include increased RNA synthesis and increased protein 
synthesis. The late effect ofPDGF stimulation of fibroblasts is cell division. In fact, 
PDGF is probably the most potent stimulator of fibroblastoid cell growth that has 
been identified. Other reported late effects ofPDGF include induction of collagenase 
gene expression and MMP-1 production (Singer GF, et al 1999). Besides, effect of 
PDGF can increase cyclo-oxygenase and prostaglandin E synthesis. PDGFs is not 
only mitogenic but also angiogenic. Three isoforms of PDGFs composing of AA，AB, 
and BB chains all exhibited angiogenic activity in a dose-dependent manner in an in 
vzvo assay system involving the chorioallantoic membrane of chick embryo (Oikawa 
T et al, 1994). 
1-3.2.2 Transforming Growth Factor 
Transforming growth factor beta (TGF-P) represents a family of related 
multifunctional growth peptides which are found most cells of the body. TGF-P is a 
25kDal homodimeric peptide composed of 2 peptide chain, of 112 amino acids in 
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length and containing a conserved motif of 9 cysteine residues. These peptide 
monomers are linked together by formation of disulphide bonds (Benson, 1998). It 
can also exist in latent form which a pro-peptide called lantency-associated peptide 
(LAP) is associated with active TGF-|3. 
TGFps act via autocrine, paracrine and endocrine modes, it is secreted in latent forms 
and needs activation. The regulatory mechanisms involving this complex process 
include the transcriptional regulatory mechanisms and the post-transcriptional 
regulatory mechanisms. There are many factors can affect the process leading to the 
abnormal expression ofTGPps, which may be the pathogenesis of many diseases. 
TGFps have mitogenic effects on fibroblasts and stimulate the chemotactic of 
fibroblast. These effects underlie the action of TGPps in tissue repair as well as in 
inflammation and fibrosis. Key to many of the effects ofTGpps on tissue repair is its 
multiple actions on regulation of extracellular matrix metabolism. It is up-regulated 
in many pathological condition. Besides, it can also up-regulate the PDGFp receptor. 
PDGF alone appears to be of limited value in accelerating wound repair in vivo, but in 
combination with other growth factors is able to modulate the normal healing process. 
An interaction between PDGF and TGF-p may be important in wound healing 
processes, but PDGF and TGF-p enhance tissue repair activities by distinct 
mechanisms. Whereas TGF-P transiently attracts fibroblasts into the wound and may 
stimulate collagen synthesis directly PDGF is a more potent chemoattractant for 
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wound macrophages and stimulates these cells to express endogenous growth factors, 
including TGF-p which, in turn, stimulates new collagen synthesis and sustained 
enhancement of wound healing over a more prolonged period of time. 
18 
CHAPTER ONE INTRODUCTION 
1.4 CHRONIC TENDON DISORDER 
"Tendinosis" is clinically defined as chronic tendon disorder with unknown etiology. 
The clinical manifestation is longstanding localized activity related pain, stiffness and 
dysfunction. However, it is not necessarily symptomatic. Ultrasound (Figure 1.4) and 
Magnetic Resonance Imaging (MRI) (Figure 1.5) have been used to envisage 
intratendinous pathology in chronic tendons (Maffulli et al, 1987; Davies et al, 1991; 
Movin et al, 1997). It affects mainly the patellar and Achilles tendons and the rotator 
cuff of the shoulder. The same pathology may also be involved in a number of other 
chronic soft tissue conditions such as tennis elbow. Empirical data suggest that 
tendinosis, if untreated, is an important factor preceeding tendon ruptures. 
Tendinosis was first used by Puddu (Puddu et al, 1990) to imply tendon degeneration 
without clinical or histological signs of intra-tendinous inflammation. However, to 
date in clinical practice, chronic tendinitis is often infer chronic tendon disorder 
associate with inflammatory response, even when more there are no obvious signs of 
inflammation around or within the affected tendons. Anti-inflammatory drugs such as 
nonsteriod anti-inflammatory drugs (NSAID) are rountinely used to treat this problem. 
A lack of systematic characterization on chronic patellar tendon disorders produces 
uncertainty in the pathogenesis and etiology of patellar tendinosis, and results in an 
ineffective treatment. As the pathogenesis, etiology and even characterization of 
tendinosis are not well defined, the nomenclature of this condition is vague and 
inconsistent. Other names for this condition include "patellar tendinopathy，，，"patellar 
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tendinosis", "patellar tendinitis", "patellar tendon disorder", “ insertion tendinitis of 
the patellar tendon", and "partial rupture of the patellar tendon". 
1,4,1 Epidemiology of Tendinosis 
Anterior knee pain associated with tenderness at the inferior pole of the patella, a 
clinical syndrome commonly called "jumper's knee", are very common in 
orthopaedic sport medicine. It has been reported that one-fourth of all athletes treated 
for a knee disorder were diagnosed with patellar tendinitis (Kujala, U.M. 1986). 
Jumper's knee is most commonly seen in athletes playing basketball, volleyball, 
football，soccer, high jump, long jump, badminton, and running (Blazina ME, 1973; 
Puddu G，1993). In most situation, tendinosis normally occurs as a result of 
work-induced or sports-induced repetitive overloading of the muscle-tendon unit. 
This is commonly seen in the patellar tendon, the Achilles tendon, the rotator cuff of 
the shoulder as well as extensor carpi radialis brevis tendon. Estimation from the 
Bureau of Labor Statistics from USA indicates that chronic tendon injuries can 
account for 48% of reported occupational illnesses (Bureau of Labor Statistics 
Bulletin 2368, 1990). In sports medicine estimated overuse injuries account for 
30-50O/O of all sports injuries. In tennis players the incidence of elbow tendinosis is as 
high as 40% (Gruchow, 1979). However, tendinosis also can occur in recreational 
athletes and patients with no association to vigorous physical activity (Rolf and 
Movin, 1997). The gender ratio of patients seems patellar tendinosis is predominant in 
male than female. 
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1,4,2 Pathogenesis and Etiology of Tendinosis 
Both intrinsic factors and extrinsic factors have been proposed to be involved in the 
pathogenesis of tendinosis. Intrinsic factors such as age (Riley et al, 1994), restricted 
blood flow and local hypoxia (Jarvinen M et al, 1997)，have also been suggested to be 
involved. Extrinsic factors including overuse and disuse (Jarvinen M et al, 1997) have 
been discussed to provoke such condition. Tendinosis has been found among elite 
athletes as well as in recreational athletes (Rolf & Movin, 1997)，however there are 
some patients with no relationship to vigorous physical activities or even “disuse，， 
(Rolf and Movin, 1997). Some authors impose a degenerative nature to the disorder, 
although tendinosis can be found also in young people. Other extrinsic and intrinsic 
factors include training errors, environmental malconditions, poor equipment, 
ineffective rules, malalignments of extremities, muscle weakness or imbalance and 
decreased flexibility are also candidates predisposing factors or risk factors to patellar 
tendinosis (Jozsa, 1997). An irreversible delayed or non-healing status, has been 
suggested (Leadbetter, 1992) as another pathogenesis of tendinosis (Astrom & 
Rausing A, 1995; Rolf et al, 1997). Another concern is that it is not known whether 
sub-stages of tendinosis exist and whether it is an ongoing process or an end stage. 
However, the true contribution of the above factors is unknown. Besides, the adverse 
effect of treatment with Ciprofloxacin (Movin et al, 1997) and other exogenous 
factors have been discussed. On the other hand, tendinosis have also been suggested 
to be a non-healing status of tendons in general (Leadbetter, 1992). 
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1.4,3 Histological Characteristics of Tendinosis 
The characteristic tissue alterations in tendinosis known about the process involves 
cells as well as the extracellular matrix, but very little understood. Histological and 
biochemical examinations suggest characteristic alterations (Astrom, 1995; Movin et 
al, 1997) including hypercellularity, neovascularization, disorganized collagen 
structure, and altered cell shapes (Figure 1.6). It has been reported that the 
proteoglycan content in tendinosis tissues is greatly increased (Movin et al, 1997)， 
and the compositional changes in glycosaminoglycans (GAGs) and core proteins have 
been recently disclosed by our group. 
1' 4,4 Clinical Aspects of Tendinosis 
1.4.4.1 History and Physical Examination 
The clinical manifestation of tendinosis is longstanding localized activity related pain 
and swelling over the inferior pole of the patella. The onset of symptoms is often 
insidious. Patients with patellar tendinosis will complain of a dull ache in the anterior 
knee after strenuous activity. They usually complain of pain when seated for long 
periods and when ascending and descending stairs. 
Tenderness at the inferior pole of the patella or in the main body of the tendon is the 
key finding in patellar tendinosis. When the knee is flexed to 90 degree, the proximal 
part of patellar tendon appears little bulge and an unclear marginal mass can usually 
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be palpated. A remarkable feature of patellar tendinosis is that there are generally few 
classical signs of soft tissue inflammation. 
1.4.4.2 Imaging Examination 
Ultrasonographic and magnetic resonance imaging are the imaging modalities 
commonly chosen in patients with patellar tendinosis for its advantage in being more 
sensitive for soft tissue. Characteristic sonographic hypoechogenic regions around the 
proximal part of patellar tendon is the appearance of patellar tendinosis. The regions 
may represent fluid accumulation due to increase of the hydrophilic proteoglycans in 
the extra-cellular matrix. On MRI examination of patellar tendinosis, the abnormal 
patellar tendon contains an oval or round area of high signal intensity on T1 and T2 
weighted images at the tendon attachment or a focal zone of high signal intensity in 
the deep layers of the tendon insertion. Tendons with patellar tendinosis have 
increased anteroposterior diameter in the affected region. 
1.4.4.3 Diagnosis of Tendinosis 
The clinical diagnosis of patellar tendinosis is based on patients' subjective reports of 
pain, and the combination of the key physical and image findings. The main 
differential diagnosis is with the patellofemoral syndrome, and the two conditions can 
coexist. Patients presenting with localized activity-related pain and disability for at 
three to six months or more. Localized tenderness and swelling presented as a 
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fusiform-widened tendon or a more localized nodules, will also be considered as 
tendinosis (Rolf&Movin, 1997). 
1.4.4.4 Management of Tendinosis 
Tendinosis is distinguished from "tendinitis" by lack of infiltration of inflammatory 
cells (Nirschl RP, 1989; Leadbetter WB, 1992). Despite this finding are used in 
current clinical management for tendinosis and chronic tendon pain often recruit 
anti-inflammatory agents (Teitz et al, 1997; Astrom, 1997). Non-steroidal 
anti-inflammatory drugs can give pain relief, but there is no convincing evidence that 
they alter the natural history. Corticosteroid injections can be used selectively in 
resistant cases, but recurrences are frequent (Almekinders LC 1998). Surgical 
excision of macroscopically pathological tissues from protracted cases yields good 
outcome when non-operative treatments fail (Rolf & Movin，1997) (Figure 1.7). 
Other therapeutic and preventative strategies to address the intra-tendinous pathology 
are lacking. 
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1.5 AIMS AND OBJECTIVES 
This study aims to characterize the fibroblasts derived from tendinosis tissues and the 
growth factors secreted from tendinosis fibroblasts. The objectives are: 
1. to characterize the proliferation capacity of tendinosis fibroblasts compared with 
healthy control; 
2. to characterize the factors secreted from tendinosis fibroblasts compared with 
healthy control; 
3. to study the angiogenic activities of the factors secreted from tendinosis 
fibroblasts compared with healthy control; 
4. to study the proteoglytic activities of the factors secreted from tendinosis 
fibroblasts compared with healthy control; 
5. to characterize the inflammatory related responses in tendinosis fibroblasts 
compared with healthy control and; 
6. to compare the finding in histological study of tendinosis with in vitro study. 
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1.6 STUDY PLAN 
Information related to the pathogenesis of tendinosis is limited. In order to obtain 
more information about the pathogenesis of tendinosis, characterization of tendinosis 
samples and the cells derived from tendinosis tissues are important. Cell culture 
model can provide a homogenous and controllable environment for the cells, which 
independent on the local environment factors in the tendon. Previous studies are more 
focus on the clinical diagnosis and management and, general histological 
characterization of tendinosis samples. This study is the first of its kind to characterize 
the cells derived from tendinosis tissues in cell culture system. In this study, 
hypercellularity, hypervascularity, matrix disruption as well as the inflammatory 
response were characterized and compared with healthy control. Since growth factors 
are playing an important role in regulation of the development, maturation of normal 
tendons as well as the repair of injured tendons, the function of two important growth 
factors (PDGFBB and TGF -P 1) in tendinosis fibroblasts were also characterized. 
To investigate this, an explant cell culture model was used to derive the fibroblasts 
from the tendon tissues. Immunocytochemical staining was used to confirm the cells 
derived from the tissues were fibroblasts. Conditioned media were collected to 
examine the factors secreted from tendinosis fibroblasts. Tendinosis fibroblasts were 
first supplemented with serum and mitogenic factor in order to examine the 
proliferation response with those stimulations. Conditioned media were used as 
supplement for tendon fibroblasts cultunng to examine whether the tendinosis 
fibroblasts can secrete mitogenic factor(s). 
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In order to examine whether tendinosis fibroblasts secrete the angiogenic factor(s) to 
enhance angiogenesis. Human endothelial cells were culture with the supplement of 
conditioned media to examine whether the media contain any factor(s) to stimulate 
the proliferation of endothelial cells. In vitro invasion assay was used to examine 
whether the factor(s) in the conditioned media can attract migration of endothelial 
cells. Moreover, in vivo CAM assay, was used to examine whether the factor(s) 
secreted by tendinosis fibroblasts can induce new blood vessel formation in animal 
model. 
Gelatinolytic ability of the factor(s) secreted by tendinosis fibroblasts was examined 
by gelatin zymography. Enzyme-linked immunosorbent assay ofMMP-1 and TIMP-1 
was used to quantify MMP-land TIMP-1 secreted by tendinosis fibroblasts. 
Inflammatory related responses in tendinosis fibroblasts were characterized and 
quantitated using PGE2 ELISA and COX-2 expression of tendinosis fibroblasts was 
examined by immunocytochemical staining. Two important growth factors for 
fibroblasts, TGF-p and PDGFBB were also characterized and quantitated using 
ELISA. 
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Figure 1.1 
The hierarchical organization of the tendon structure from collagen fibrils to the entire 
tendon (Jozsa, 1997). 
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Figure 1.2 
Location of human patellar tendon, the extension of the common tendon of insertion 
of the quadriceps femoris muscle, takes its origin from the apex or distal pole of the 
patella and inserts distally into the tibial tuberosity (Josza，1997). 
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Figure 1.3 
Wound healing can be divided into three overlapping phase: inflammation, 
proliferation, and maturation. The inflammatory phase of healing overlaps the 
inflammatory response (Redrawn from Martinez-Hernandez A, Amenta PS. 
Sports-induced inflammation. In: Leadbetter WB, Burkwalter JA, Gordon SL, eds. 
Basic concepts in wound healing. Perk Ridge, ILiAAOS, 1990). 
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Figure 1.5 
Magnetic resonance imaging in patellar tendinosis patients. High signal intensity area 
rcprcscnls the pathological site. 
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Figure 1.6 
Typical H&E staining of (A) patellar tendinosis tissues and (B) healthy patellar 
tendon tissue. Higher cellularity and less collagen staninability was typically found in 
tendinosis tissues. 
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Figure 1.7 
Removal of pathological tissues from a patellar tendinosis patients during the surgical 
treatment. 
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CHAPTER TWO MA TERIALS AND METHODOLOG Y 
CHAPTER 2 MATERIALS AND METHODOLOGY 
2.1 COLLECTION OF HUMAN TISSUES SAMPLES 
2.1.1 Collection of Human Patellar Tendinosis Samples 
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2.1 COLLECTION OF HUMAN TISSUES SAMPLES 
Subjects of the present study were recruited from the Department of Orthopaedics and 
Traumatology in Prince of Wales Hospital, Hong Kong in 1999 and 2000. All patients 
were asked for consent and fully informed of all research objectives and procedures 
prior to operation. 
2丄1 Collection of Human Patellar Tendinosis Samples 
Patients with patellar tendinosis cases were presented with localized activity-related 
pain for at least six months. Inclusion criteria also include localized tenderness and 
swelling (Rolf & Movin 1997). Patients with previous medical history of tendon 
injuries and disorders were excluded from the study. Ultrasound or magnetic 
resonance imaging (MRI) were performed to clearly define cases with intra-tendinous 
hypoechogenic areas or hyper-intense respectively (Rolf & Movin 1997, Movin et al 
1997a&b, Movin et al 1998). Patients were operated when conservative management 
including physiotherapy fails to relieve the symptoms. Open biopsies were obtained 
from macroscopically disorder areas during rountine surgical management as cases. 
The dimension of samples were depended on the size of the pathological area. 
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2-1-2 Collection of Healthy Human Patellar Tendon Samples 
The control subjects of the present study were also recruited from the Department of 
Orthopaedics and Traumatology in Prince of Wales Hospital, Hong Kong in 1999 and 
2000. Healthy patellar tendon samples were obtained from patients undergoing 
anterior cruciate ligament (ACL) reconstruction. Remnant of patellar tendon autograft 
(approximately 1cm x 0.5cm x 0.3cm) were sampled for primary explant culture in 
order to obtain the healthy tendon fibroblasts. 
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2.1 TISSUE CULTURE 
2.2.1 Reagents 
2.2.1.1 Dulbecco's Modified Eagle's Medium 
Dulbecco's Modified Eagle's Medium (DMEM) powder was purchased from Gibco. 
The powder was dissolved in 900ml Milli-Q water. The package was rinsed with a 
small amount of Milli-Q water to dissolve all traces of powder and added to the 
medium. 3.7g sodium bicarbonate (NaHCOs) was supplemented for each liter of 
medium after all the DMEM powder was dissolved. While stirring, pH of the medium 
was adjusted to 7.2 to 7.4 by titration with IM Sodium Hydroxide solution (NaOH) or 
IM Hydrochloric Acid (HCl). Additional Milli-Q water was added to bring the 
medium solution to 1 liter. Medium was sterilized by filtering through a 0.22|Lim 
membrane (Millipore) under sterilized condition. The filtered medium was dispensed 
aseptically into sterile containers. 10ml of DMEM was sampled and incubated for 
contamination test. The stock medium was stored at 4°C. 
2.1.1.2 Phosphate Buffered Saline 
Phosphate Buffered Saline (PBS) was prepared by dissolving 8.0g Sodium Chloride 
(NaCl)，0.2g Potassium Hydrogen Phosphate (KH2PO4), 0.2g Potassium Chloride 
(KCl), 1.15g Sodium Phosphate (NasPO*) in 900ml Milli-Q water. The pH was 
adjusted to 7.4 at room temperature by titrating with IM NaOH or IM HCl. 
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Additional Milli-Q water was added to bring the solution to 1 liter. PBS was sterilized 
by autoclaving at 121°C, 15 psi for 30 minutes. 
2.1.1.3 Fetal Bovine Serum 
Fetal Bovine Serum (FBS) was purchased from Gibco. The serum was heat 
inactivated at 56°C for 30 minutes. 10ml aliquots were prepared aseptically and stored 
at -20°C. 
2.1.1.4 Trypsin/EDTA Solution 
Trypsin/EDTA solution was purchased from Gibco. The solution contains 0.25% 
trypsin and 0.53mM ethylenediamine tetraacetic acid (EDTA), tetrasodium salt in 
Hank's Balanced Salt Solution (HBSS) without calcium and magnesium ions. 10ml 
aliquots were prepared aseptically and stored at —20°C. 
2.1.1.5 Pencillin-Streptomycin-Neomycin Antibiotics Mixture Solution 
Penicillin-Streptomycin-Neomycin (PSN) Antibiotics Mixture Solution was 
purchased from Gibco. The solution contains 5mg/ml of penicillin, 5mg/ml of 
streptomycin and lOmg/ml of neomycin in 0.85% saline. Five milliliter aliquots were 
prepared aseptically and stored at -20°C. 
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2.1.1.6 Trypan Blue Solution 
Trypan blue crystal was purchased from Sigma. Trypan blue solution was prepared by 
dissolving trypan blue crystal in PBS at a concentration of 0.1% (w/v). The solution 
was stored at 4°C after sterilized filtration. 
2.2,2 Culture of Human Tendon Fibroblasts 
2.2.2.1 Primary Explant Culture 
The method was modified from Freshney (Freshney, 1992). Fresh tendon samples 
were rinsed with sterilized PBS twice and 1% PSN in PBS once. The fatty tissues and 
blood vessels were removed. The samples was cut into small cubes (1mm x 1mm) 
which were placed in serum-free DMEM and their explants were briefly trypsinized 
by 0.25% trypsin/EDTA solution for 5 minutes. DMEM with 10% FBS were then 
used to neutralize the effect of trypsin. The explants were placed in 35mm culture dish 
(Falcon) and incubated with DMEM with 10% FBS at 37�C，5% CO2, 95% humidity. 
The culture medium was changed every three days. 
2.2.2.2 Subculture and Maintenance of Tendon Fibroblasts 
After fibroblasts migrating out from the explant tissue and reaching confluent 
monolayer culture, the culture dish was washed once with PBS. One milliliter of 
O.250/0 trypsin/EDTA solution was added in culture dish in order to detech the 
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adherent cells. The culture dish was incubated at 37�C for 3 minutes and then gently 
rapped to detach the cells from the dish. One milliliter of DMEM with 10% FBS was 
added to neutralize the trypsin activity. The cells were then centrifuged at 1700rpm 
for 5 minutes and washed with serum free DMEM once. The fibroblasts were 
resuspended in DMEM with 10% FBS. Viable cells were determined by 
hemocytometer in trypan blue exclusion test. Cell at density of 2 xlO^ cells per 25cm^ 
culture flask (Coming) was seeded for subculture. All fibroblasts used in the 
subsequent experiments were restricted from second passage to forth passage. 
The primary explant tissues in 35mm culture dish were supplemented with 1ml 
culture medium and the fibroblasts seeded in the 25cm^ culture flask were 
supplemented with 3ml culture medium for culture maintenance. The fibroblasts were 
incubated at 37°C, 5% CO2, 95% humidity. The culture medium was changed every 
three days. 
2.2.2.3 Immunocytochemical Staining of Fibroblasts 
Collagen is the major body protein produced by connective tissue fibroblasts. Prolyl 
4-hydroxylase catalyses the formation of 4-hydroproline in collagen and other 
proteins with collagen-like amino acid sequences by the hydroxylation of certain 
proline resides in peptides linkages. The antibody reacts with the beta-subunit of 
prolyl 4-hydroxylase thus act as the marker for the fibroblasts (Janin A et al, 1990). 
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Tendinosis and healthy tendon fibroblasts were trypsinized from the culture flask and 
seeded in 4 wells chamber slide (Nunc). When the fibroblasts grow to confluency, 4% 
paraformaldehyde/phosphate buffer was used to fix the fibroblasts for 24 hours in 4°C. 
The fibroblasts were first performed blocking procedure using 1% BSA in PBS for 30 
minutes. Then it quenched with 0.5% hydrogen peroxide for 20 minutes; and 
incubated with goat monoclonal anti-human fibroblasts primary antibody (DAKO) at 
1:100 dilution overnight in humid chamber at 4°C. After 4 washes in PBS, the slides 
were incubated with secondary antibodies, a biotinylated anti-goat IgG (DAKO) at 
1:100 dilution for 30 minutes. After 4 washes in PBS, the slides were incubated in 
avidin-biotin complex (DAKO Kit) at 1:100 dilution for 60 minutes. The slides were 
exposed to a 1% solution of 3,3'-diaminobenzidine tetrahydrichloride (DAB) for 4 
minutes for color development. Finally the slides were emerged into distilled water, 
counterstained in Mayer's hematoxylin, dehydrated through graded alcohol and 
mounted with glycerol. 
2-23 Culture of Human ECV304 Endothelial Cell Line 
2.2.3.1 Human ECV304 Endothelial Cells 
Human ECV304 endothelial cell line (CRL-1998, ACCT) was purchased from the 
American Type Culture Collection. It is a spontaneously transformed immortal 
endothelial cell line established from the vein of an apparently normal human 
umbilical cord. The cells were characterized by a cobblestone monolayer growth 
pattern，high proliferation potential and anchorage dependency with contact inhibition 
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2.2.3.2 Subculture and Maintenance of Human ECV304 Endothelial Cells 
The procedures for subculture of human ECV304 endothelial cells were same as those 
described in section 2.2.2.2 except the human ECV304 endothelial cells were used. 
Culture medium for human ECV304 endothelial cells was prepared by adding 5ml 
FBS and 1ml PSN antibiotics mixture solution into 94ml DMEM. The DMEM with 
5% FBS and 1% PSN antibiotics mixture solution was stored at 4°C. 
Human ECV304 endothelial cells seeded in 75cm^ culture flask (Falcon) were 
supplemented with 10ml culture medium. The cells were incubated at 3TC, 5% CO2, 
95% air humidity. The culture medium was changed every three days. 
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2.3 PREPARATION OF CONDITIONED MEDIUM 
2.3,1 Collection of Conditioned Medium 
When fibroblasts reached around 80% confluent, the medium in culture flasks was 
discarded. The culturewere rinsed with serum free DMEM twice. Three milliliter 
serum free DMEM was added into each 25cm^ culture flask and incubated at 37°C, 
5% CO2 and 95% humidity for 24 hours. The conditioned medium was collected in a 
15ml centrifuge tube and then centrifuged at SOOOipm for 10 minutes to remove cell 
debris. The conditioned medium was aliquoted and stored at -20 until use 
(Descalzi et al 1995). The collections of conditioned medium from tendinosis and 
healthy tendon fibroblasts were restricted to second to forth passage of the cells. After 
the protein amount in the conditioned media were measured, serum free DMEM was 
used to dilute the conditioned medium and standardize the protein amount of 
500ng/ml in conditioned media. 
2丄2 Concentration of Conditioned Medium for CAM Assay 
The conditioned media used in CAM assay were concentrated by Centriprep-3 
concentrators (Amicon). Centriprep concentrators are disposable ultrafiltration 
devices for concentrating biological samples (Figure 2.1). 
The sample container's twist-lock cap was loosened and filtrate collector was 
removed. Conditioned medium from tendinosis and healthy patellar tendon 
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fibroblasts were added, then the filtrate collector was carefully reinserted back into 
the sample container and the cap locked. The concentrator was then centrifuged at 
3000xg, 25V for 95 minutes. The filtrate in filtrate collector was disposed and 
centrifuged again at SOOOxg, 25V for 35 minutes again. The retentate in sample 
collection was collected, aliquoted and stored in -80°C until used. The concentrated 
conditioned media were standardized with protein amount of 4jLig/ml. 
2.3.3 Bradford Protein Assay 
Bradford protein assay was conducted to measure the protein content of the 
conditioned medium. The protein assay based on the method of Bradford, a 
dye-binding assay in which a differential color change of a dye occurs in response to 
various concentrations of protein. 
160|al of protein standard and samples were added to the culture wells of a 96-well 
plate (Coming). 40|al of the Bio-Rad dye reagent was then applied into the wells and 
mixed well. The plate was placed on a microplate shaker and incubated at room 
temperature for about 10 minutes. Absorbance of the samples were measured with a 
microplate reader (Universal microplate reader ELX800UV from Bio-Tek 
Instruments Inc, USA) at 595nm. Amount of protein in the conditioned medium was 
calculated from the BSA standard. Results were expressed as the average protein 
amount in each group. Data from each group was compared using Student's t-test, 
P<0.05 was regarded as significant difference. 
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2.4 PROLIFERATION RESPONSE OF TENDON FIBROBLASTS 
2,4,1 Effect of FBS on BrdU Incorporation 
Tendinosis fibroblasts and healthy tendon fibroblasts were trypsinized and washed 
with serum free DMEM. The fibroblasts were seeded in 96 well microtiter plate with a 
seeding density of 3x10^ cells per well in triplicate. DMEM with 10% FBS 
supplementation was used to culture the fibroblasts. The fibroblasts were incubated at 
37°C, 5% CO2，95% humidity and assessed the BrdU incorporation on 0 ， 9 出 ， 
12th and 15th day. Results were expressed as the average optical density of BrdU 
incorporation in each group and various time points. Data from each group was 
compared using Student's t-test in each time point, p<0.01 was regarded as significant 
difference. 
For measuring the proliferative response at various levels of FBS supplementation, 
seeded cells were exposed to FBS free DMEM for 24 hours, and then changed to 0%, 
50/0 10% and 20% FBS in DMEM. BrdU incorporation assay was carried out at day 6 
of culture. Results were expressed as the average optical density of BrdU 
incorporation in each group and each serum concentration. Data from each group was 
compared using Student's t-test in each serum concentration, p<0.05 was regarded as 
significant difference. 
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2.4.2 Effect of PDGFBB on BrdU Incorporation 
Samples were seeded in 96 well microtiter plate with density of 5x10^ cells per well in 
triplicate. The fibroblasts were cultured in DMEM with 5% FBS and lOng/ml human 
recombinant Platelet Derived Growth Factor (PDGF) isoform B supplementation. 
The fibroblasts were incubated at 37°C, 5% CO2, 95% humidity. BrdU incorporation 
assay was performed after 48 hours. Results were expressed as the average optical 
density of BrdU incorporation in each group. Data from each group was compared 
using Student's t-test, p<0.05 was regarded as significantly difference. 
2.4.3 Effect of Conditioned Medium on BrdU Incorporation 
Tendinosis and healthy tendon fibroblasts were trypsinized from the culture flask. 
Serum-free DMEM was used to wash out the serum around the fibroblasts in triplicate. 
The fibroblasts were seeded in 96 well microtiter plate with density ofSxlO^ cells per 
well. The fibroblasts were cultured in tendinosis or healthy patellar tendon 
conditioned medium with 5% FBS supplementation. The fibroblasts were incubated 
at 37°C, 5% CO2, 95% humidity. BrdU incorporation assay was performed after 48 
hours. Results were expressed as the average optical density of BrdU incorporation in 
each group. Data between two groups were compared using Student's t-test, p<0.05 
was regarded as significant difference. Data within each group were compared using 
one-way ANOVA, p<0.05 was regarded as significant difference. 
2.4.4 Effect of Conditioned Medium on Human ECV304 Endothelial Cells 
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Human ECV304 endothelial cells were trypsinized and washed with serum free 
DMEM. The cells were seeded in 96 well microtiter plate at a density of 5x10^ cells 
per well in triplicate. The cells were cultured in serum-free DMEM for 24 hours. 
After 24 hours, the serum-free DMEM was changed to tendinosis or healthy patellar 
tendon conditioned medium with 2% FBS supplementation. The fibroblasts were 
incubated at ?>TC, 5% CO2, 95% humidity. BrdU incorporation assay was performed 
after 48 hours. Results were expressed as the average optical density in each group. 
Data from each group was compared using one way ANOVA, p<0.05 was regarded as 
significantly difference. 
2.4.5 Effect of Anti-PDGFsB Antibodies in Conditioned Medium on Human 
ECV304 Endothelial Cells 
Anti-PDGFeB antibodies was purchased from R&D systems. It was reconstituted by 
dissolving the powder in 1ml PBS to final concentration of Img/ml. First, conditioned 
media with 2% FBS was mixed with anti-PDGpBB with the final concentration of 0, 
0.05，0.025, 0.0125 |ig/ml. The mixture supplemented with antibodies was used to 
culture the tendinosis and healthy tendon fibroblasts in same method which described 
in section 2.4.4. BrdU incorporation assay was performed after 48 hours. Results were 
expressed as the average optical density of BrdU incorporation in each group. Data 
from each group was compared using Student's t test, p<0.05 was regarded as 
significant difference. 
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2,4,6 5-bromo-2，-deoxyuridine (BrdU) Incorporation Assay 
The techniques of BrdU incorporation assay is based on the incorporation of the 
pyrimidine analogue BrdU instead of thymidine into DNA of proliferating cells. After 
its incorporation into DNA, BrdU is detected by immunoassay. Since cellular 
proliferation requires the replication of cellular DNA, the monitoring of DNA 
synthesis is an indirect parameter of cell proliferation. After the BrdU incorporated 
into the DNA of proliferating cells, the anti-BrdU-POD will further bind to the BrdU 
incorporated, cellular DNA. The immune complexes are detected by the subsequent 
substrate reaction. The reaction product is quantified by measuring the absorbance at 
the wavelength of 370mn. 
BrdU incorporation ELISA (Enzyme Linked Immunosorbent Assay) kit was 
purchased from Roche. All the reagents and procedures were followed the instruction 
listed in the user manual. However, the incubation time for the anti-BrdU antibodies 
and substrate were modified. 
lOOjal of samples with triplicates in a 96 well microtitter plate (Coming) were 
incubated at 37�C，5% CO2 and 95% humidity. lOjil/well of BrdU labeling solution 
was added in each well and the cells were incubated at 37�C for 4 hours in dark. Tap 
off the medium and 200|al/well FixDenat solution was added at room temperature for 
30 minutes. After removal of FixDenat solution thoroughly by tapping, lOO^il/well 
anti-BrdU-POD working solution was added to the wells which were then incubated 
for 60 minutes at 37�C. Anti-BrdU-POD solution was removed by tapping culture 
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wells were rinsed three times with 200|Lil/well of washing solution. lOOjil/well of 
substrate solution was then added for incubation at room temperature for 50 minutes. 
Absorbance of the samples were measured with a microplate reader at 370mn with 
reference wavelength of 492nm. 
Blank was performed in each experimental setup. It provided the information about 
the unspecific blinding of BrdU and anti-BrdU-POD conjugate to the microtitter plate. 
The bank absorbance value not exceeding 0.1 was subtracted from experimental 
values. 
Background control without BrdU labeling was performed once with the respective 
cell system (tendinosis fibroblasts, healthy tendon fibroblasts and human ECV304 
endothelial cells). Information about the unspecific binding of the anti-BrdU-POD 
conjugate to the cells in the absence of BrdU. This value should not exceed 0.1 too. 
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2.5 INVASION ASSAY 
Invasion assay allows assessment of the chemotaxis. Transwells containing 
polycarbonate membrane with pores of a specific size (S.Oja) (Falcon) were coated 
with matrigel and inserted into conventional 24-well culture plates (Nunc). Cells 
would be cultured on the top of matrigel. Conditioned medium from different cells 
was placed in the lower chambers. Cells digest the matrigel matrix and migrate onto 
the polycarbonate membrane. The rate of migration correlated with the chemotactic 
effect of conditioned medium. Cell number on the membrane could also be easily 
quantitated under light microscope after haematoxyline staining. 
2.5,1 Reagents 
Matrigel 
Matrigel matrix was purchased from Becton Dickinson Labware/Collaborative 
Biomedical Products. It is a soluble basement membrane extract that gels to form a 
reconstituted basement membrane. It promotes differentiation of endothelial cells, 
which is suitable for in vitro angiogenesis assays. The major components of matrigel 
are laminin，collagen IV, entactin, and heparan sulfate proteoglycan. It was thawed in 
an ice-water bath，aliquoted in and then stored at -20�C. Repeated freezing and 
thawing should be avoided since properties may change. 
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2.5,2 Procedures 
The method was modified from Garrido (Garrido et al, 1995). Apparatus including 
transwells, 24-well culture plate (Nunc), pipet tips and sterile Milli-Q water was 
pre-chilled at 4 � C (Fig. 2.2). Matrigel aliquot was thawed in an ice-water bath. An 
equal amount of cold sterile Milli-Q water was added and gently mixed. 15jLil diluted 
matrigel was used to coat the polycarbonate membrane of each transwell (Falcon), 
which was then placed in a well of 24-well plate (Nunc). The coating was performed 
at After all transwells were coated, the plate with transwells was incubated at 
37°C for 30-60 minutes in order to allow the matrigel polymerize. 
After polymerization, 1x10^ cells (ECV304) in 200jal of serum free DMEM was 
seeded in each upper transwell while 0.5ml conditioned medium from tendinosis and 
healthy patellar tendon fibroblasts with standardized protein amount of 500ng/ml, 
DMEM with 5% FBS or serum-free DMEM were placed in the lower culture wells at 
the bottom in triplicate. The culture plate was finally incubated at 37°C，5% CO2，95% 
humidity for 24 hours. After the incubation, the medium was aspirated from culture 
wells. 500 microliter absolute methanol pre-chilled at -20^C was added to fix the cells. 
The plate was put in -20�C refrigerator for 10 minutes. The culture medium was 
aspirated from transwells. Matrigel coated on transwells was then removed by 
scrubbing with small swabs soaked with PBS while the methanol was aspirated away. 
Afterwards, the transwells were stained using standard haematoxyline for 5 minutes. 
The polycarbonate membranes were cut out from the transwells with a scalpel. The 
membranes were finally mounted on glass slides with xylene-based histomount (DPX, 
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Fluke). The cell number was then assessed by cell counting under light microscope in 
lOOx magnificantion and images were captured using imaging analysis software 
(Metaphor Version 4.5, Universal Imaging, USA) (Figure 2.3). Cells in the central 
part were counted under microscope (Teramoto N et al, 2000). Results were expressed 
as the total cell number per five views in each group. Data from each group was 
compared using Student's t test, p<0.05 was regarded as significant difference. 
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2.6 CHICK CHORIOALLANTOIC MEMBRANE MODEL 
(CAM ASSAY) 
Fertilized eggs were purchased from Agriculture and Fisheries Department. Total 69 
fertilized eggs were used in this assay. The procedures were modified from 
Imela-Arispe,M.L (Iruela-Arispe,M.L et al, 1999) and MydloJ.H (MydloJ.H et al, 
1998). After cleaning with 70% ethanol, the eggs were incubated at 37^C, 70% 
humidity for 4 days. At day 4, a small window was made at the region of air sac of the 
eggs. The shell membrane was then peeled off by means of a pair of sterile forceps to 
expose the chorioallantoic membrane (CAM) of chick embryo (Figure 2.4). Two 
sterile circular filter paper discs with 6mm diameter soaked with 30^1 conditioned 
medium being tested were applied onto the surfaces of the growing CAMs. The 
window were sealed with Tegaderm (3M) and the eggs were incubated for another 48 
hours. At day 6，the window was re-opened. The filter paper discs were removed with 
a sterile forcep. 
The temporal change of the blood vessel growth pattern was photographically 
recorded at day 4 and day 6. A ruler was placed besides the shell of the egg for 
magnification calibration. The position, magnification power and distance between 
the CAMs and the digital camera were fixed throughout the experiment. 
Imaging analysis (Metaphor Version 4.5, Universal Imaging, USA) was used to 
measure the blood vessel length in the CAM. The blood vessels on the CAM were 
first sketched on the digital image. Only the length but not the thickness of the blood 
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vessel will be sketched. The unit of measurement in the length of blood vessel, pixel, 
will be converted into centimeter by calibration of the ruler next to egg in the photo. 
The ruler in each photo was used to calibrate the pixel length to actual length of blood 
vessel on the CAM. Results were expressed as average length increased in blood 
vessels in each group between day 4 and day 6. Data from each group was compared 
using one way ANOVA, p<0.05 was regards as significant difference. 
I 
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2.7 SODIUM DEDECYLSULPHATE POLYACRYLAMIDE GEL 
ELECTROPHORESIS 
2.7.1 Samples Preparation 
Before Sodium Dedecylsulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
was started, the conditioned media from tendinosis fibroblasts and healthy tendon 
fibroblasts were mixed with 2x sample loading buffer at 1:1 ratio. The sample mixture 
was boiled for 10 minutes and spinned down. They were kept at room temperature 
until samples loading. 
2.7.2 Reagents 
Electrophoretic Buffer (lOx) 
lOx Electrophoretic Buffer was composed of 0.25M Trizma-base, 1.92M glycine and 
1% (w/v) SDS. The pH was adjusted to 8.3. The buffer was stored at room 
temperature. 
Resolving Gel Buffer (2x) 
2x resolving gel buffer was prepared by dissolving 30.28g of Trizma-base and 2g of 
SDS in 900ml of Milli-Q water. The pH was adjusted to 6.8 and the volume was 
brought to 1 litre. The resolving buffer was stored at 4°C. 
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Stacking Gel Buffer (2x) 
2x stacking gel buffer was prepared by dissolving 90.84g of Trizma-base and 2g of 
SDS in 900ml of Milli-Q water. The pH was adjusted to 8.8 and the volume was made 
to 1 litre. The stacking buffer was stored at 4°C. 
I 
30% Acrvlamide Solution 
Acrylamide solution was prepared by dissolving 146g of acrylamide and 4g of 
Bis-acrylamide in 500ml Milli-Q water. The solution should be kept in dark at 4°C. 
30% Ammonium Persulphate 
30% ammonium persulphate was prepared by dissolving 60mg of ammonium 
persulphate (Sigma) in 200)^ 1 of Milli-Q water. 
Sample Loading Buffer (2x) 
2x sample loading buffer was prepared by mixing 0.757g of Trizma-base (Sigma), 2g 
of SDS and lOg of sucrose in 90ml of Milli-Q water. 5ml of 2-mercaptoethanol and Ig 
ofbromophenol blue were added and mixed well. The volume was brought to 100ml 
and stored at room temperature. 
2.73 Procedures 
SDS-PAGE was performed using Mini-Protean II electrophoresis cell purchased from 
Bio-Rad. Electrophoresis cell components were cleaned thoroughly by Milli-Q water. 
Glass plate sandwiches were assembled properly. In the meantime, 15% resolving gel 
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was prepared by mixing 7.5ml 30% Acrylamide Solution, 7.5ml Resolving Buffer. 
Resolving gel solution was applied into the glass plate sandwiches once after the 
addition of 21)1130% ammonium persulphate (Sigma) and \2.5\i\ TEMED (Bio-Rad). 
After 45-minute polymerization, 4% stacking gel solution was prepared by mixing 
0.8ml Acrylamide Solution, 3.3ml Stacking Buffer and 2.2ml Milli-Q water, in which 
12|LI1 30% ammonium persulphate and 6|li1 TEMED were added. The prepared 
stacking gel mixture was applied to the sandwich and the combs were inserted into the 
stacking gel. After another 45 minutes, combs were removed. The setup was put into 
the tank containing electrophoretic buffer. Pre-stained protein marker (Bio-Rad) and 
samples were loaded into the wells. Samples were run at constant voltage of 80V until 
the blue dye was run out of the gel. 
2.7.4 Silver Stain ing 
Pre-fixing Solution 
Pre-fixing solution was made up of 500ml methanol, 100ml acetic acid and 400ml 
Milli-Q water. 
Silver Stain Solution 
The silver stain solution was made up of 4g silver nitrate, 7ml ammonium hydroxide 
and 0.378g sodium hydroxide in 500ml Milli-Q water. 
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Developer Solution 
Developer solution was made up of 0.05g citric acid and 1ml formaldehyde in 500ml 
Milli-Q water. 
Procedures 
The gel transferred into pre-fixing solution for 30 minutes. It was the washed with 
Milli-Q water for 10 minutes once and then wash in 50% methanol for 30 minutes 
twice. After washing the gel will immersed in freshly prepared silver stain solution for 
another 30 minutes. The gel was rinsed with Milli-Q water for 1 hour before, 
developer solution was added for 5 to 15 minutes. The reaction was stopped by 7% 
acetic acid when desired coloration was obtained and wash it again before scanning. 
2,7.5 Gelatin Zym ography 
The procedures were modified from Miyake H (Miyake H et al, 1997). Conditioned 
medium from tendinosis and healthy tendon fibroblasts with standardized protein 
content of 4|Lig/ml were separated by SDS-PAGE (as described in section 2.7.3 on 
lOo/o (mass/vol) polyacrylamide gels containing gelatin (Sigma) at Img/ml under 
non-reducing conditions. After electrophoresis, the gels were washed for an hour at 
room temperature in SOmM TRIS/HCl, pH 7.5，containing 5mM CaCls, (Sigma) IjLiM 
ZnClz (Sigma), 0.02% (mass/vol) NaNs (Sigma) and 2.5% (v/v) Triton X-100 
(Sigma). The gels were further incubated in the same buffer containing 1% (v/v) 
Triton X-100 (Sigma) for 18 hours at 37°C and stained with Coomassie brilliant blue 
for an hour. After 10 minutes of destaining and 1 hour washing with Milli-Q water, the 
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gelatinolytic activity was observed as a clear band. Negative control was performed 
by incubating the gels with same buffer containing 20mM EDTA (Sigma) (Rankin 
CA et al, 1996; Ahrens DK et al, 1996; Todor DR et al, 19998). 
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2.8 ENZYME LINKED IMMUNOSORBENT ASSAY 
2.8.1 Quantitation of MMP-1 
Matrix Metalloproteinase-1 (MMP-1) ELISA system for quantitative determination 
of active form and latent form MMP-1 was purchased from Calbiochem. The assay 
based on a two site ELISA "sandwich" format. Standard and samples were incubated 
in microtitre plate which precoasted with anti-MMP-1 antibody. All MMP-1 (active 
form and latent form) are bound to the wells. The second polyclonal antibody to 
MMP-1 was then bound to MMP-1, which was detected using donkey anti-rabbit 
horseradish peroxidase. The amount of peroxidase bound to each well was determined 
by the addition of substrate. The concentration of MMP-1 in a sample was determined 
by interpolation from a standard curve. 
All the reagents were brought to room temperature before starting. A serial dilution of 
the pro-MMP-1 standard in serial dilution was prepared using the assay buffer. lOOjul 
of standards or samples were added to each well for incubation at room temperature 
for 2 hours. The wells were washed thoroughly for five times using the washing buffer. 
lOOfil of MMP-1 conjugate was added to each well for incubation at room 
temperature for 1 hour. After thorough washing for five times, lOO i^l per well of color 
reagent was added. Color was developed by keeping the wells in the dark at room 
temperature for 30 minutes. Finally lOO i^l per well of Stop Solution was 
supplemented to stop the reaction. The absorbance of the samples was measured 
within 30 minutes by a microplate reader at 450nm with reference wavelength 595mn. 
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Quantity of MMP-1 in the samples was calibrated against the pro-MMP-1 standard 
curve. Results were expressed as the average MMP-1 secretion per 3 million cells per 
24 hours. Data from each group was compared using Student's t test, p<0.05 was 
regarded as significant difference. 
2.8.2 Quantitation of TIMP-1 
Tissue Inhibitor of Metallorpoteinase-1 (TIMP-1) ELISA system for quantitative 
determination of TIMP-1 was purchased from Calbiochem. The assay also based on 
same theory as MMP-1 ELISA kit. 
All the reagents were brought to room temperature before starting. A serial dilution of 
the TMP-l standard in serial dilution was prepared using the assay buffer. lOOjil of 
standards or samples were added to each well for incubation at room temperature for 1 
hour. The wells were washed thoroughly for four times using the washing buffer. 
lOOfil of TIMP-1 conjugate was added to each well for incubation at room 
temperature for 30 minutes. After thorough washing for four times, lOOjul per well of 
color reagent was added. Color was developed by keeping the wells in the dark at 
room temperature for 30 minutes. Finally 100|li1 per well of Stop Solution was 
supplemented to stop the reaction. The absorbance of the samples was measured 
within 30 minutes by a microplate reader at 450nm with reference wavelength 595nm. 
Quantity of TIMP-1 in the samples was calibrated against the TIMP-1 standard curve. 
Results were expressed as the average TIMP-1 secretion per 3 million cells per 24 
hours. Data from each group was compared using Student's t test, p<0.05 was 
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regarded as significant difference. 
2,8.3 Quantitation of Prostaglandin E2 
Quantikine� ELISA Kit for quantitative determination of human Prostaglandin E2 
(PGE2) was purchased from R&D systems. This assay based on the competitive 
binding technique in which PGE2 present in a sample completes with a fixed amount 
of alkaline phosphate-labeled PGE2 for site on a mouse monoclonal antibody. During 
incubation, the mouse monoclonal antibody becomes bound to the goat anti-mouse 
antibody coasted on the microplate. Following a wash to remove excess conjugate and 
unbound sample, a substrate solution is added to the wells to determine the bound 
enzyme activity. 
150|11 of Assay Buffer, lOOjil of standards and samples, 50^1 of PGE2 Conjugate and 
50|11 ofPGE2 Antibody Solution were added. The mixture was incubated for 2 hours. 
After three washes with 400|li1 Washing Buffer, 200|li1 ofpNPP Substrate was added in 
each well and incubated for 1 hour. 50|al of Stop Solution was added in each well to 
stop the reaction. The absorbance of the samples was measured within 30 minutes by 
a microplate reader at 450mn with reference wavelength 595mn. Quantity of PGE2 in 
the samples was calculated from the PGE2 standard curve. Results were expressed as 
tiie average PGE2 secretion per 3 million cells per 24 hours. Data from each group was 
compared using Student's t test, p<0.05 was regarded as significant difference. 
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2.8.4 Quantitation ofTGF-pi 
Quantikine® ELISA Kit for quantitative determination of activated human TGFpi 
was purchased from R&D systems (Catalog no. DBIOO). This assay employs the 
quantitative sandwich enzyme immunoassay technique. TGF-P 1 soluble receptor type 
II has been pre-coated onto a microplate and the TGF-P 1 present in samples is bound 
to those immobilized receptors. 
Samples Preparation 
To 0.5ml conditioned medium, 0.1ml IN HCl was added and mixed well. It was 
incubated at room temperature for 10 minutes and neutralized by adding 0.1ml 1.2N 
NaOH/0.5M Hepes. The activated conditioned medium would then be subject to the 
ELISA assay. The concentration read off the standard curve must be multiplied by the 
dilution factor 1.4. 
Procedures 
200)^ 1 of TGFpl standard or activated conditioned medium samples were added to 
each well. The test samples were then incubated at room temperature for 3 hours. 
Each well was aspirated and washed with Ix Wash Buffer for three times. 200|il of 
TGFpl Conjugate was added to each well and incubated for 1.5 hours at room 
temperature. After three washes, 200j^l of substrate solution was added to each after 
20 minutes. 50|il Stop Solution was added and well mixed in each well. The optical 
was determined within 30 minutes, using a microplate reader at 450nm with 
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wavelength correction at 595mn. Results were expressed as the average TGPpi 
secretion per 3 million cells per 24 hours. Data from each group was compared using 
Student's t test, p<0.05 was regarded as significant difference. 
2,8.5 Quantitation of PDGFBB 
Quantikine® ELISA Kit for quantitative determination of human PDGFBB was 
purchased from R&D systems. This assay employs the quantitative sandwich enzyme 
immunoassay technique. PDGF-Rp/Fc chimera has been pre-coated onto a microplate 
and PDGFBB present is bound by immobilized receptor. 
lOOjal of Assay Diluent RDIX was first added in each well. lOOjul per well of 
PDGFBB standards or conditioned medium samples was added for incubation at room 
temperature for 2 hours. Each well was washed with 400|il Wash Buffer four times. 
200|il per well of PDGFBB Conjugate was then added to each well for incubation at 
room temperature for 1.5 hours. After three washes, 200j^l of substrate solution was 
added to each well for another 30 minutes at room temperature. Finally, 50|li1 per well 
Stop Solution was added and mixed well. The optical density was determined within 
30 minutes, using a microplate reader at 450mn with wavelength correction at 595mn. 
Results were expressed as the average PDGFBB secretion per 3 million cells per 24 
hour. Data from each group was compared using Student's t test, p<0.05 was regarded 
as significant difference. 
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2.9 IMMUNOCYTOCHEMICAL STAINING 
2.9.1 Immunocytochemical Staining of PDGFPReceptor 
All procedures were same as described in section 2.2.2.3 except the fibroblasts 
incubated with dilution 1:100 goat monoclonal anti-human PDGFrP primary antibody 
(R&D). 
2.9.2 Immunocytochemical Staining of Cyclooxygenase 2 
All procedures were same as described in section 2.2.2.3 except the fibroblasts 
incubated with dilution 1:100 mouse monoclonal anti-human Cyclooxygenase 2 
(COX-2) primary antibody (Santa Cruze) and secondary antibody of biotinylated 
anti-mouse IgG (DAKO) at 1:100 dilution was instead of biotinylated anti-goat IgG. 
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2.10 STATISTICAL ANALYSIS 
All results were expressed as the mean士standard deviation (SD) and error plot was 
used to present the result graphically. Different statistical tests were used and it was 
stated in each section. Normally, p<0.05 was regarded as significant difference unless 
otherwise specified. 
All analyses were made by SPSS for Windows (version 10.0). 
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Figure 2.1 
Centriprep-3 with molecular weight cut-off of 3,000 daltons (Amicon) 
Conditioned medium were concentrated by Centriprep-3 which was centrifuged with 
3,000 xg at 25°C for 130 minutes and the retenate was collected. 
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Setup for invasion assay - transwell with 8.0 i^m polycarbonate membrane for 
24-well plate (Falcon) 
(A) Transwells were used in invasion assays. 
(B) Matrigel was coated on the membrane. Cells to be tested were cultured in 
transwells while chemoattractant such as conditioned medium was placed in the lower 
chamber. 
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Figure 2.3 
Figure showing the sampling method for cell counting used in invasion assay. First, 
using the microscope to determine the central of the membrane. Image was captured 
using imaging analysis software and count the cells under the view (blue square). 
Then count the cells in another four views with no overlapping with the central view 
(yellow squares). 
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Procedures of in vivo test - chick chorioallantoic membrane (CAM) assay 
(A) At day 4 incubation, a window was opened at the region of air sac�(B) shell 
membrane was peeled off to expose the CAM. (C) a filter paper disc soaked with 
conditioned medium were placed onto the CAM (D) the window was sealed by a 3M 
Tegaderm and the egg was incubated for 48 hours. 
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3.1 PATIENT'S INFORMATION 
General information of the patient recruited for tendinosis samples and healthy 
patellar tendon samples were listed in Table 3.1. Ten patients with patellar tendinosis 
were recruited in this study. Patients' age ranged from 15 to 40 and average was 
27.8±9.27. Two female and eight male patients were recruited in this study. All of 
these patients fulfilled the clinical and radiological criteria for tendinosis, which they 
all have activity related longstanding localized pain in the proximal part of patellar 
tendon, and with tenderness on palpation with a low echogenous area or a hyper 
intense area verified by ultrasound or MRI, respectively. They all participated in 
various recreational sports. All patients had undergone physiotherapy (range 3-8 
months), and had used oral NSAID treatment over shorter periods of time. In no case 
they had received local cortisone injections. Before the surgical treatment, all patients 
failed to response to conservative modalities, presenting persistent pain and affecting 
activities of daily life. 
For the healthy patellar tendon samples, ten patients' age ranged from 17 to 40 and 
median of age was 24.8±7.89. Three female and seven male patients were recruited in 
this study. There was no statistical significant difference between the age of two 
groups (p=0.446) (Figure 3.1). The control subjects had no previous history or clinical 
signs of patellar tendon injury. All of these patients had used occasional NSAID and 
physiotherapy during a pre-operative planning session for at least 6 months from the 
injury. They all participated in recreational sports. 
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3.2 PRIMARY EXPLANT CELL CULTURE 
3.2.1 Cell Morphology of Tendinosis Fibroblasts 
Human patellar tendon and tendinosis fibroblasts in the cell culture expressed typical 
morphology of cultured fibroblasts. The fibroblasts exhibited an elongated, flattened 
and spindle shaped and bipolar morphology on the culture dish (Figure 3.2). 
3.2.2 Homogeneity in Subculture 
Homogeneity of fibroblasts as the culture was continually passed up to the forth 
passage. Fibroblasts used for all assays and the conditioned medium collected were 
from the second to forth passages (Figure 3.3). 
The fibroblast marker was stained with a brown color at immunocytochemistry 
(Figure 3.4). All cells derived from patellar tendon and tendinosis tissues both 
expressed positive signal. Staining was mainly found in cytoplasm of the cells 
3.2.3 Protein Content in Conditioned Medium 
Average protein content in tendinosis conditioned medium was 610.2±5.38ng/3 
million cells/24 hours and average protein content in healthy tendon fibroblasts 
conditioned medium was 583.2±2.52ng/3 million cells/24 hours (Figure 3.5). There 
was no significant difference between the protein content of two groups (p=0.168). In 
77 
CHAPTER THREE — F^SULTS 
order to standardize the protein content in conditioned media for following assays, 
serum-free DMEM was used to dilute and standardize the conditioned media with 
protein content of 500ng/ml. 
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3.3 PROLIFERATION RESPONSE OF TENDON FIBROBLASTS 
3.3.1 Effect of FBS on BrdU Incorporation 
BrdU incorporation of both healthy patellar tendon and tendinosis fibroblasts was 
gradually increased around ninth day of culture (Figure 3.6). The difference between 
BrdU incorporation of tendinosis and healthy tendon fibroblasts was statistical 
significant in all tested day, i.e. day 0 (p=0.002)，day 9 (p<0.001), day 12 (p=0.005) 
and day 15 (p=0.002) but not day 3 (p=0.032) and day 6 (p=0.014). 
For measuring the BrdU incorporation at various levels of FBS supplementation, 
tendinosis fibroblasts showed higher BrdU incorporation in all tested serum 
concentration (Figure 3.7). The difference between BrdU incorporation of tendinosis 
and healthy fibroblasts in the supplementation of 5% FBS (p=0.003), 10% FBS 
(p=0.014) and 20% FBS (p=0.012) was statistical significant. The difference between 
BrdU incorporation of tendinosis and healthy tendon fibroblasts with no serum 
supplementation was not statistical significant (p-0.168). Increase BrdU 
incorporation was observed for both tendinosis and healthy tendon fibroblasts when 
the concentration of FBS supplementation increased. 
3.3.2 Effect of PDGFBB on BrdU Incorporation 
BrdU incorporation of tendinosis fibroblasts and healthy tendon fibroblasts cultured 
with lOng/ml PDGFBB and 5% F B S supplementation was compared (Fig. 3.8). 
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P D G F B B supplementation stimulated higher BrdU incorporation in tendinosis 
fibroblasts when compared with healthy control. The difference between BrdU 
incorporation of tendinosis and healthy tendon fibroblasts was statistical significant 
(p<0.001). Besides, difference between BrdU incorporation with Ong/ml and lOng/ml 
P D G F B B supplementation for both tendinosis (p<0.001) and healthy tendon 
fibroblasts (p<0.001) were also statistical significant. 
33,3 Effect of Conditioned Medium on BrdU Incorporation 
Tendinosis conditioned media supplementation stimulated higher BrdU incorporation 
in tendon fibroblasts (tendinosis and healthy tendon fibroblasts) when compared with 
healthy tendon fibroblasts conditioned media (Figure 3.9) and the difference was 
significant (p<0.001). However, supplementation of healthy tendon fibroblasts 
conditioned media showed no difference in BrdU incorporation when compared with 
control (p=0.960). 
Tendinosis fibroblasts showed higher proliferation in supplementation of tendinosis 
fibroblasts conditioned media (p<0.001) and healthy tendon fibroblasts conditioned 
media (p<0.001) when compared with healthy tendon fibroblasts. 
3.3.4 Effect of Conditioned Medium on Human ECV304 Endothelial Cells 
Supplementation of tendinosis conditioned media stimulated higher BrdU 
incorporation in human ECV304 endothelial cells (Figure 3.10) when compared with 
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healthy tendon fibroblasts conditioned media and the difference was significant 
(p<0.001). However, supplementation of healthy tendon fibroblasts conditioned 
media did not stimulate higher BrdU incorporation in human endothelial cells when 
compared with control (p=0.986). 
Effect of Anti-PDGFsB Antibodies in Conditioned Medium on Human 
ECV304 Endothelial Cells 
Effect of conditioned medium with various concentrations of anti-PDGpBB antibodies 
on human ECV304 endothelial cells was showed in Figure 3.11. Anti-PDGpBB 
antibodies at the dosage of 0.05|Lig/ml suppressed the tendinosis conditioned media 
induced BrdU incorporation in human endothelial cells but not at the dosage of 
0.025^g/ml (p=0.105) and 0.0125iLig/ml antibodies when compared with the dosage 
of 0|ag/ml antibodies (p<0.001). 
Since supplementation of healthy tendon fibroblasts conditioned media had no effect 
on the BrdU incorporation in human endothelail cells, anti-PDGFsB antibodies at the 
dosage up to O.OS i^g/ml had no effect on suppressing BrdU incorporation when 
compared with 0|ag/ml antibodies (p=0.820). 
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3.4 INVASION ASSAY 
Tendinosis conditioned medium promote the migration of human ECV304 
endothelial cells (Figure 3.12 and 3.13). The difference between the migrated cell 
number of tendinosis conditioned medium and healthy tendon fibroblasts conditioned 
medium on chemotactic effect to human ECV304 endothelial cells was statistical 
significant (p<0.001). The difference between migrated cell number of tendinosis 
conditioned medium group and control group was also statistical significant (p<0.001) 
but not between healthy tendon fibroblasts conditioned medium group and control 
group (p=0.858). 
82 
CHAPTER THREE — F^SULTS 
smooth, continued and did not show any abnormality. Compared to the control 
(normal condition) group, the morphology between two groups was similar (Figure 
3.15). 
DMEM with PDGFgn (Positive Control) 
P D G F B B treated group behaves similar to the tendinosis group, especially with Ing/ml 
P D G F B B supplementation. The blood vessels on the CAM were also highly branched 
and the numbers of capillaries were much more than those of the control group. The 
capillary density was very high. In some cases, the trunk blood vessels even became 
bigger (Figure 3.16). 
Tendinosis Conditioned Medium 
After exposure to the tendinosis conditioned medium, the blood vessels on the CAM 
were highly branched and the numbers of capillaries were much more than those of 
the control group. The capillary density was very high. In some cases, the trunk blood 
vessels even became bigger (Figure 3.17). 
Healthy Conditioned Medium 
Macroscopically, after exposure to the healthy tendon fibroblasts conditioned medium, 
the blood vessels on the CAM were similar to the negative control group. The blood 
vessels were not highly branched as the tendinosis group. The capillary density was 
lower than those in tendinosis group (Figure 3.17). 
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3.6 SODIUM DEDECYLSULPHATE POLYACRYLAMIDE GEL 
ELECTROPHORESIS (SDS-PAGE) 
3.6.1 Silver Staining 
After SDS-PAGE electrophoresis, the protein with different molecular sizes were 
separated. Figure 3.18 demonstrated that there were 5 protein bands with approximate 
molecular weight of 80, 70，50, 55 and 10 kDa were present in tendinosis conditioned 
media and healthy tendon fibroblasts conditioned media. 
3.6.2 Gelatin Zymography 
Representative zymogram of tendinosis conditioned media and healthy tendon 
fibroblasts conditioned media was showed in Figure 3.19. A broader and clear band 
was shown in the lane of tendinosis conditioned medium samples. A clear band also 
existed in healthy tendon samples. The molecular size of the band was similar to the 
MMP-1 standard (band 1). After the zymogram incubated with 20mM EDTA，an 
inhibitor ofMMPs, the clear bands were disappeared. 
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3.7 ENZYME LINKED IMMUNOSORBENT ASSAY 
3.7.1 Quantitation of MMP-1 
Average amount of MMP-1 in tendinosis conditioned medium was 0.719±0.212ng/3 
million cells/24 hours and the average amount of MMP-1 in healthy tendon 
fibroblasts conditioned medium was 0.427±0.223ng/3 million cell/24 hours (Figure 
3.20). The difference of MMP-1 amount between tendinosis conditioned medium and 
healthy conditioned medium was statistical significant (p=0.008). 
3.7.2 Quantitation of TIMP-1 
Average amount of TIMP-1 in tendinosis conditioned medium was 5.894±0.148ng/3 
million cells/24 hours and the average amount of TIMP-1 in healthy tendon 
fibroblasts conditioned medium was 6.026士0.095ng/3 million cells/24 hours (Figure 
3.21). The difference of TIMP-1 amount between tendinosis conditioned medium and 
healthy conditioned medium was statistical significant (p=0.028). 
•？. 73 Quantitation of Prostaglandin E2 
Average amount of PGE2 in tendinosis conditioned medium was 37.069±2.857pg/3 
million cells/24 hoursa and the average amount of PGE2 in healthy tendon fibroblasts 
conditioned medium was 23.348±1.101pg/3 million cells /24 hours (Figure 3.22). The 
difference of PGE2 amount between tendinosis conditioned medium and healthy 
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conditioned medium was statistical significant (p<0.001). 
5.7.4 Quantitation of TGF-/31 
Average amount of TGFpi (both active and latent form) in tendinosis conditioned 
medium was 37.918±0.656pg/3 million cells/24 hours and the average amount of 
TGFpi in healthy tendon fibroblasts conditioned medium was 0.0733±0.07278pg/3 
million cells/24 hours (Figure 3.23). The difference of TGFpi amount between 
tendinosis conditioned medium and healthy conditioned medium was statistical 
significant (p<0.001). 
3.7.5 Quantitation of PDGFBB 
Average amount of PDGFBB in tendinosis conditioned medium was 7.427±0.539pg/3 
million cells/24 hours and the average amount of PDGFBB in healthy tendon 
fibroblasts conditioned medium was 0.181±0.102pg/3 million cells/24 hours (Figure 
3.24). The difference of PDGFBB amount between tendinosis conditioned medium 
and healthy conditioned medium was statistical significant (p<0.001). 
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3.5 CHICK CHORIOALLANTONIC MEMBRANE MODEL 
(CAM ASSAY) 
Quantitation on the Length of Blood Vessel: 
The average increase of blood vessel length in tendinosis conditioned medium was 
4.4983±3.3295, healthy tendon fibroblasts conditioned medium was 0.0629+2.667, 
D M E M was 0.751±3.07, Ing/ml P D G F B B was 3.4438±1.4192 and, control was 
2.2316±1.9942 (Figure 3.14). The difference between tendinosis conditioned medium 
supplementation healthy tendon fibroblasts conditioned medium was statistical 
significant (p=0.013) but not between DMEM (p=0.295), control (p=0.774) and 
Ing/ml P D G F B B (P二0.980). The difference between healthy tendon fibroblasts 
conditioned medium and DMEM was not statistical significant (p=0.996). 
Morphology: 
Normal Condition fControD 
Macroscopically, the whole membrane was covered by many allantoic vessels after 2 
days of incubation. The blood vessels were continuous, straight and well-branched 
(Figure 3.15). 
DMEM�Control� 
The gross morphology of the membrane in DMEM treated group is similar to that in 
the negative control group. Under the filter paper discs, the capillaries were still very 
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3.8 IMMUNOCYTOCHEMICAL STAINING 
3,8.1 Immunocytochemical Staining of PDGPPReceptor 
Positive staining was observed in the cytoplasm of the tendon fibroblasts. The 
expression ofPDGFp receptor in tendinosis fibroblasts was different from the healthy 
control. When compare with healthy control, heavy staining was found in tendinosis 
fibroblasts (Figure 3.25). 
Immunocytochemical Staining of Cyclooxygenase 2 
Positive staining was observed in the cytoplasm of the fibroblasts. The expression of 
COX-2 in tendinosis fibroblasts was different from the healthy control. When 
compare with healthy control, heavy staining was found in tendinosis fibroblasts 
(Figure 3.26). 
CHAPTER THREE — F^SULTS 
Code Gender Age Diagnosis Code Gender Age Diagnosis 
(Year) (Year) 
1 “""“F 25 Hea l t hy” 11 F 25 Tendinosis 
~ 2 M \1 Healthy 12 M 40 Tendinosis 
3 M ^ Healthy 13 M 19 Tendinosis 
4 M fs Healthy 14 M ^ Tendinosis 
5 F 40 Healthy 15 M Tendinosis 
6 F 3S Healthy \6 M ^ Tendinosis 
7 M 23 Healthy \7 M ^ Tendinosis 
8 M 23 Healthy 18 F \5 Tendinosis 
9 M 20 Healthy 19 M 24 Tendinosis 
10 M 21 Healthy 20 M 22 Tendinosis 
(A) 
Tendinosis Healthy Control 
Female 2 3 
Male 8 1 
(B) 
Table 3.1 
The general informat ion for the patients rccruitcd in this study. Ten tendinosis 
samples were obtained from patients with patellar tendinosis with the age ranged from 
15 to 40, two female and eight male patients. Ten healthy patellar samples were 
obtained from the patients underwent A C L rcconsli tut ion with the age ranged from 1 7 
to 40, three female and seven male patients. Chi square test showed no significant 
dif lcroncc between the gender of two groups {p=l) . 
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Error plot showing average age of patients recruited in this study. Ten patients with 
tendinosis with average age 27.8±9.27 were recruited in this study. Ten patients who 
undergoing ACL reconstruction with average age was 24.8±7.89 were recruited in 
this study as healthy control group. There was no statistical significant difference 
between the age of two group (p=0.446). 
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Figure 3.2 
Representative pictures of primary explant culture of (A) tendinosis tissue and (B) 
healthy patellar tendon�At day 7 of culture, numerous human tendinosis fibroblasts 
migrated from the explant and exhibited a bipolar morphology on the culture dish. 
There is no difference between the morphology of fibroblasts derived from health 
patellar tendon and patellar tendinosis�The arrowhead indicated the tissue explant. 
(Magnification: 200x) 
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Figure 3.3 
Representative pictures of tendon fibroblasts culture at day 7 after subculture in 
second passage. The general morphology of tendinosis fibroblasts showed similar to 
the healthy tendon fibroblasts and between second passage and forth passage. (A) 
Tendinosis fibroblasts in second passage, (B) healthy human patellar tendon 
fibroblasts in second passage, (C) tendinosis fibroblasts in forth passage and (D) 
healthy tendon fibroblasts in forth passage (Magnification: 200x). 
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Figure 3.4 
Representative pictures of immunocytochemical staining of prolyl-4-hydroxylase on 
healthy tendon and tendinosis fibroblasts cultures. Positive staining was observed on 
the cytoplasm of the fibroblasts. Tendon fibroblasts were cultured in the chamber 
slides after 3 days in the second passage of subculture (A) immunocytochemical 
staining of tendinosis fibroblasts and (B) healthy tendon fibroblasts. Tendon 
fibroblasts were cultured in the chamber slides after 3 days in the forth passage of 
subculture (C) immunocytochemical staining of tendinosis fibroblasts and (D) 
healthy tendon fibroblasts (Magnification: 200x). 
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Error plot showing the average protein content in conditioned media of tendinosis and 
healthy tendon fibroblasts. Average protein amount in tendinosis conditioned medium 
was 610.2±5.38ng/3 million cells/24 hours and average protein amount in healthy 
tendon fibroblasts conditioned medium was 583.2±2.52ng/3 million cells/24 hours. 
There was no significant difference between the protein amount of two group 
(p=0.168). 
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Figure 3.6 
Error plot showing the BrdU incorporation of fibroblasts culture at different days of 
subculture. Tendon fibroblasts were seeded with density of 3000 cells/well. BrdU 
incorporation assay was performed at day 0，3, 6, 9 and 15. The difference between 
BrdU incorporation of tendinosis and healthy tendon fibroblasts was statistical 
significant in day 0 (p=0.002), day 9 (p<0.001), day 12 (p=0.005) and day 15 
(p=0.002) but not day 3 (p=0.032) and day 6 (p-0.014). 
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Figure 3.7 
Error plot showing the effect of FBS on BrdU incorporation of tendinosis and healthy 
tendon fibroblasts at day 6. Tendon fibroblasts were seeded with density of 3000 
cells/well. The difference between proliferation response of tendinosis and healthy 
fibroblasts in the supplementation of 5 % FBS (p-0.003) was statistical significant but 
not 10% FBS (p=0.014) and 20% FBS (p=0.012). The difference between BrdU 
incorporation of tendinosis and healthy tendon fibroblasts with no serum 
supplementation was not statistical significant (p=0.168). 
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Error plot showing BrdU incorporation of tendon fibroblasts with lOng/ml PDGFBB 
supplementation after culture for 48 hours. Tendon fibroblasts were seeded with 
density of 5000 cells/welL The difference between BrdU incorporation of tendinosis 
and healthy tendon fibroblasts was statistical significant (p<0.001). Besides, 
difference between BrdU incorporation in Ong/ml and lOng/ml PDGFBB 
supplementation for both tendinosis (p<0.001) and healthy tendon fibroblasts 
(p<0.001) were also statistical significant. 
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Figure 3.10 
Error plot showing BrdU incorporation of human ECV304 endothelial cells with 
different conditioned media supplementation. Human ECV304 endothelial cells were 
seeded with density of 5000 cells/well. The difference of BrdU incorporation between 
the effect of conditioned media to human ECV304 endothelial cells was statistical 
significant (p<0.001). The difference of BrdU incorporation between the tendinosis 
conditioned medium and control was statistical significant (pO.OOl) but not between 
healthy tendon fibroblasts conditioned medium and control (p=0’986). Tendinosis 
fibroblasts conditioned medium supplementation gives the highest proliferation 
where the proliferation in healthy conditioned medium supplementation and control 
show no difference. 
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Figure 3.11 
Effect of conditioned media with various concentration of anti-PDOFEE antibodies on 
human ECV304 endothelial cells. Anti-PDGFeB antibodies at the dosage of 
0.05|^g/ml suppressed the tendinosis conditioned media induced BrdU incorporation 
in human endothelial cells but not at the dosage of 0.025|^g/ml (p=0.105) and 
0.0125|ag/ml antibodies when compared with the dosage of Ojug/ml antibodies 
(pO.OOl). Since supplementation of healthy tendon fibroblasts conditioned media 
had no effect on the BrdU incorporation in human endothelail cells, anti-PDOFee 
antibodies at the dosage up to 0.05|ig/ml had no effect on suppressing BrdU 
incorporation when compared with O^ig/ml antibodies (p=0.820). 
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Figure 3.12 
Error plot showing migrated human ECV304 endothelial cells to the membrane 
through matrigel under microscope. The difference between of tendinosis conditioned 
medium and healthy tendon fibroblasts conditioned medium on chemotactic effect to 
human ECV304 endothelial cells was statistical significant (p<0.001). The difference 
between of tendinosis conditioned medium and control was statistical significant 
(pcO.OOl) but not between healthy tendon fibroblasts conditioned medium and 
control (p=0.858). Attracted cell under tendinosis conditioned medium is highest and 
there is no difference between the migrated cells under healthy tendinosis fibroblasts 
conditioned medium and control。 
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Figure 3.13 
ECV304 human endothelial cells migrated onto the membrane under the influence of 
(A) healthy tendon fibroblasts conditioned medium and (B) tendinosis conditioned 
medium (lOOx magnification). Endothelial cells invaded through matrigel and 
migrated onto the membrane. The migrated cells under tendinosis conditioned 
medium is higher than healthy tendon fibroblasts conditioned medium. 
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Figure 3.14 
Error plot showing the average increase in blood vessel length after incubated with 
different conditioned media in C A M assay. The difference between tendinosis 
conditioned medium supplementation healthy tendon fibroblasts conditioned medium 
was statistical significant (p=0.013) but not between D M E M (p=0.295), control 
(p-0.774) and Ing/ml PDGFBB (P二0.980). The difference between healthy tendon 
fibroblasts conditioned medium and D M E M was not statistical significant (p=0.996). 
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Figure 3.15 
Angiogenesis assay in chorioallantoic membrane (CAM). (A) morphology of the 
C A M of a normal fertilized egg without any treatment at day 4 and (B) after 48 hours 
incubation at 37^C with 65% humidity. (C) morphology of C A M of a fertilized egg at 
day 4 and (D) after 48 hours incubated with filter paper disc soaked with D M E M。 
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Figure 3.16 
Angiogenesis assay in chorioallantoic membrane (CAM). (A) morphology of C A M 
of a fertilized egg at day 4 and (B) after 48 hours incubated with filter paper soaked 
with Ing PDGFBB- (C) morphology of C A M of a fertilized egg at day 4 and (D) after 
48 hours incubated with filter paper disc soaked with D M E M。 
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Figure 3.17 
Angiogenesis in chorioallantoic membrane (CAM). (A) morphology of C A M of a 
fertilized egg at day 4 and (B) after 48 hours incubated with tendinosis fibroblasts 
conditioned medium. (C) morphology of C A M of a fertilized egg at day 4 and (D) 
after 48 hours incubated with healthy tendon fibroblasts conditioned medium. (E) 
morphology of C A M of a fertilized egg at day 4 and (F) after 48 hours incubated with 
filter paper disc soaked with D M E M . 
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Figure 3.18 
SDS-PAGE gel showing the protein separation of the tendinosis conditioned medium 
and healthy tendon fibroblasts conditioned medium with silver staining. There are 
bands around the size 70kDa, 55kDa, 50kDa and lOkDa in both tendinosis and 
healthy tendon fibroblasts conditioned medium. 
Lane 1: Pre-stained Molecular Marker 
Lane 2: Tendinosis Conditioned Medium 
Lane 3: Healthy Tendon Fibroblasts Conditioned Medium 
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Figure 3.19 
Gelatin zymography showing (A) gelatinolytic activities in different conditioned 
medium and (B) with E D T A inhibition. The size of the bands in tendinosis and 
healthy tendon fibroblasts conditioned medium is similar to the M M P - 1 standard. 
Those clear bands are abolished by presence of EDTA. 
Lane 1: MMP-1 Standard 
Lane 2 & 3: Tendinosis Conditioned Medium 
Lane 4 & 5: Healthy Tendon Fibroblasts Conditioned Medium 
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Error plot showing the quantity of M M P - 1 in different conditioned media。Human 
M M P - 1 ELISA was used to quantify the total M M P - 1 existing in tendinosis 
conditioned medium and healthy tendon fibroblasts conditioned medium。Average 
amount of M M P - 1 in tendinosis conditioned medium was 0.719±0.212ng/3 million 
cells/24 hours and the average amount of M M P - 1 in healthy tendon fibroblasts 
conditioned medium was 0.427±0.223ng/3 million cells/24 hours. The difference of 
MMP-1 amount between tendinosis conditioned medium and healthy conditioned 
medium was statistical significant (p=0.008). 
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Error plot showing the quantity of TIMP-1 in different conditioned media. Human 
TIMP-1 ELISA was used to quantify the total TIMP-1 in tendinosis conditioned 
medium and healthy tendon fibroblasts conditioned medium. Average amount of 
TIMP-1 
in tendinosis conditioned medium was 5.894±0.148ng/3 million cells/24 
hours and the average amount of TIMP-1 in healthy tendon fibroblasts conditioned 
medium was 6.026±0.095ng/3 million cells/24 hours. The difference of TIMP-1 
amount between tendinosis conditioned medium and healthy conditioned medium 
was statistical significant (p=0.028). 
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Error plot showing the quantity of PGE2 in different conditioned media。Human PGE2 
ELISA was used to quantify the PGE2 in tendinosis conditioned medium and healthy 
tendon fibroblasts conditioned medium. Average amount of PGE2 in tendinosis 
conditioned medium was 37.069±2.857pg/3 million cells/24 hours and the average 
amount of PGE2 in healthy tendon fibroblasts conditioned medium was 
23.348±1.101pg/3 million cells/24 hours. The difference of PGE2 amount between 
tendinosis conditioned medium and healthy conditioned medium was statistical 
significant (p<0.001). 
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Error Plot showing the quantity of human TGF-p 1 in different conditioned media. 
Human TGF-p 1 ELISA was used to quantify the TGF-P 1 in tendinosis conditioned 
medium and healthy tendon fibroblasts conditioned medium. Average amount of 
TGFpi (both active and latent form) in tendinosis conditioned medium was 
37.918±0.656pg/3 million cells/24 hours and the average amount of TGFpi in 
healthy tendon fibroblasts conditioned medium was 0.0733±0.07278pg/3 million 
cells/24 hours. The difference of TGFpi amount between tendinosis conditioned 
medium and healthy conditioned medium was statistical significant (p<0.001). 
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Error Plot showing the quantity of human PDGFBB in different conditioned media. 
Human PDGFBB E L I S A was used to quantify the PDGFBB in tendinosis conditioned 
medium and healthy tendon fibroblasts conditioned medium. Average amount of 
PDGFBB in tendinosis conditioned medium was 7.427±0.539pg/3 million cells/24 
hours and the average amount of PDGFBB in healthy tendon fibroblasts conditioned 
medium was 0.181±0.102pg/3 million cells/24 hours。The difference of PDGFBB 
amount between tendinosis conditioned medium and healthy conditioned medium 
was statistical significant (p<0.001). 
— T i l ^ 一 ― 一 — 一 一 . 一 — … 
CHAPTER THREE RESULTS 
Figure 3.25 
Representative pictures of the immunocytochemical staining of PDGF-P receptor. 
Tendon fibroblasts were cultured in the chamber slides after 3 days in the second 
passage of subculture. Positive staining was observed on the cytoplasm of the 
fibroblasts. (A) Immunocytochemical staining of PDGF-p receptor in tendinosis 
fibroblasts and (B) healthy tendon fibroblasts. Tendinosis fibroblasts have a higher 
stainability when compare with the healthy tendon fibroblasts (Magnification: 200x) 
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Figure 3.26 
Representative pictures of the immunocytochemical staining of COX-2. Tendon 
fibroblasts were cultured in the chamber slides after 3 days in the second passage of 
subculture. Positive staining was observed on the cytoplasm of the fibroblasts. (A) 
Immunocytochemical staining of COX-2 in tendinosis fibroblasts and (B) healthy 
tendon fibroblasts. Tendinosis fibroblasts have a higher stainability when compare 
with the healthy tendon fibroblasts。(Magnification: 200x) 
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4.1 HIGHER PROLIFERATION CAPACITY OF TENDINOSIS 
FIBROBLASTS 
4丄1 Tendinosis Fibroblasts are More Prone to PDGFBB Stimulation 
From our results, higher proliferation potential of tendinosis fibroblasts was found in 
the supplementation of FBS (in all tested concentration) when compared with healthy 
control. Higher proliferation of tendinosis fibroblasts was also found in the 
supplementation of lOng/ml PDGFBB when compared with healthy control. Higher 
proliferation in tendinosis fibroblasts is likely associated with more PDGFp receptor 
expression in tendinosis fibroblasts. Tendinosis fibroblasts also showed higher 
proliferation when supplemented with tendinosis conditioned media or healthy 
tendon fibroblasts conditioned media. It indicated that the tendinosis fibroblasts were 
more prone to those stimulations thus gave higher proliferation. 
Previous studies from other researchers in our research team demonstrated that 
PDGFBB is a mitogen for fibroblasts; dosage of lOng/ml was reported to stimulate 
significant proliferation for rat tendon fibroblasts (Chan et al, 1997). Our results also 
indicated the dosage of lOng/ml PDGFBB promoted significant proliferation in tendon 
fibroblasts; however, tendinosis fibroblasts were more prone to PDGFBB stimulation. 
Higher proliferation was found in tendinosis fibroblasts. 
For the BrdU incorporation of tendon fibroblasts along different duration of culture, 
higher proliferation rate of tendinosis fibroblasts observed after day 6 of culture. 
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Since tendinosis fibroblasts have higher proliferation capacity; accumulated cell 
number of tendinosis group at day 6 should be higher than that of healthy control. As 
a result, more cells with higher proliferation thus gave a more significant difference 
between the proliferation of tendinosis fibroblasts and healthy tendon fibroblasts. 
Tendinosis is clinically regarded as a chronic condition. Chronic injury is 
characterized by slow insidious onset, implying an antecedent sub-threshold spectrum 
of structural damage leading to crisis episode that is heralded by pain and/or signs of 
inflammation lasting months to years distinguished by persistent symptoms without 
resolution (Lundborg et al, 1978). From the result of BrdU incorporation assay in the 
study, it clearly showed that the tendinosis fibroblasts were not in silent end stage of a 
degenerative disorder but rather were in a highly active and proliferative process. This 
suggestion was also supported by an increased proteoglycan deposition in tendinosis 
(Rolf et al, 1997; Movin et al, 1997; Movin et al, 1998). Hypercellularity occurs in the 
early healing phase of any tendon injury, where the proliferating tenocytes retain the 
fibroblastic appearance and inflammatory cells are abundant (Satoh et al., 1996; 
Nagata et al., 1996). Fibroblast is the source of collagen production, protein mediators 
of repair and matrix proteoglycans as well as some cytokines, such as PDGFBB, 
TGFpl (O'Brien et al., 1997; Chan et al, 1998). 
4.1-2 Tendinosis Fibroblasts Secrete Mitogenic Factor� for Proliferation 
Our results showed that supplementat ion of tendinosis condi t ioned media p romoted 
higher prol i ferat ion in tendon fibroblasts (both tendinosis and heal thy tendon 
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fibroblasts) when compared with supplementation of healthy tendon fibroblasts 
conditioned media, no matter for tendinosis fibroblasts or healthy tendon fibroblasts. 
However, supplementation of healthy tendon fibroblasts conditioned media did not 
promote tendon fibroblasts proliferation when compared with control. PDGFBB and 
TGF-p were both characterized and quantified in conditioned media. Both tendinosis 
and healthy tendon fibroblasts secreted PDGFBB and TGF-P. However, tendinosis 
fibroblasts secreted more PDGFBB and TGF-p when compared with healthy control. 
A lot of growth factors are existed in FBS, such as PDGFBB and TGF-P (Freshney, 
1992). Both PDGFBB (Agren M S et al, 1999) and TGF-p (Levi-Schaffer F et al, 1999) 
are mitogenic to fibroblasts, which can promote fibroblasts proliferation. Since 
tendinosis fibroblasts secreted more PDGFBB and TGF-p, higher proliferation in 
tendon fibroblasts after supplementation of tendinosis conditioned media is likely 
associated with those factors. However, supplementation of healthy tendon fibroblasts 
conditioned media showed no difference when compared with control. It indicated 
that although healthy tendon fibroblasts secreted PDGFBB and TGF-p but the amount 
was not enough to enhance tendon fibroblasts proliferation. For tendinosis fibroblasts, 
the expression of P D G F p receptors was up-regulated and secretion of PDGFBB and 
TGF-p were increased. Such kind of autocrine stimulation of growth by enhancing 
endogenous synthesis of a growth factor is one possible mechanism for a cell to 
eliminate or substantially reduce the requirement for specific exogenous growth 
factors. 
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4丄3 Up-regulation of PDGFfi Receptors is Associated with TGF-P and 
PDGFBB Secreted in Tendinosis Fibroblasts 
The expression of P D G F p receptor was significantly increased in tendinosis 
fibroblasts when compared with healthy control. It may explained why the tendinosis 
fibroblasts are more proliferative and more prone to stimulations. Especially for both 
types of fibroblasts supplemented with PDGFBB supplementation, higher proliferation 
was found in tendinosis fibroblasts. It indicated that tendinosis fibroblasts were more 
sensitive to PDGFBB stimulation. Detectable level of PDGFp receptor expression was 
also found in healthy tendon fibroblasts. It maybe explained by the stimulatory factors 
in FBS stimulation. Since the FBS contained a lot of growth stimulatory factors, some 
of them may up-regulate the expression of PDGFp receptors. PDGFp receptor could 
be up-regulated by P D G F and TGF-P (Ichiki Y at al, 1995; Inaba T et al, 1996; Smits 
et al., 1992; Harts et al., 1988). These two growth factors were also highly secreted in 
tendinosis fibroblasts. It is likely that the up-regulation of PDGFp receptor is 
associated with elevated secretion of these two growth factors, resulting in tendinosis 
fibroblasts are more prone to stimulation. The relationship of up-regulation of PDGFp 
receptor and secretion of PDGFBB and TGF-p can result in higher proliferation of 
tendinosis fibroblasts. 
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4丄4 Up-regulation of PDGFP Receptor is Commonly Observed in 
Pathological Condition 
P D G F p receptor is greatly up-regulated in response to injury, and its up-regulation 
appears to be a prerequisite for maximal responsiveness to P D G R Up-regulation of 
P D G F p receptor level in human fibroblasts has been observed in many diseases. For 
examples, expression of PDGFp receptor by dermal fibroblasts was increased in skin 
wounds (Karane et al, 1991) and in fibroblastic proliferative disorders (Klareskog et 
al, 1990). These conditions were accompanied by connective tissue cell proliferation 
and this up-regulation may function to increase the responsiveness of the cells to 
stimulation by P D G F (Thomas et al, 1996). 
The current study demonstrated higher proliferation capacity of tendinosis fibroblasts. 
It also provides the information for speculating the causes of higher proliferation 
capacity of tendinosis fibroblasts. W e demonstrated that tendinosis fibroblasts secrete 
more PDGFBB and TGF-P which were mitogenic and they were capable of 
up-regulating PDGFp receptor (Ichiki Y at al, 1995; Inaba T et al, 1996). 
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4.2 TENDINOSIS FIBROBLATS SECRETE ANGIOGENIC FACTOR 
ENHANCING ANGIOGENESIS 
Angiogenesis is the formation of new capillaries from pre-existing one. This process 
is important to many normal and pathological phenomenon. Normal events include 
wound healing, embryonic development and development of the corpus luteum. The 
turnover rate of capillaries is very low. It involves the growth of endothelial cells, 
invade the endothelial cells to target site and formation of new blood capillaries. Our 
study using indirect model: endothelial cell proliferation assay, invasion assay and 
C A M assay to study the relationship between the secretion of growth factors from 
tendinosis fibroblasts and the hypervascularity found in tendinosis specimens. 
Tendinosis Fibroblasts Secrete Factor(s) Enhancing Angiogenesis 
Our results showed that supplementation of tendinosis conditioned media promote 
higher proliferation of human endothelial cells when compared with supplementation 
of healthy tendon fibroblasts conditioned media. On the other hand, supplementation 
of healthy tendon fibroblasts conditioned media did not promote proliferation when 
compared with control. It indicated that tendinosis fibroblasts secreted some factor(s) 
which enhance endothelial cells proliferation. Inhibition assay using anti-PDCFEE 
antibodies could suppress the proliferation induced by tendinosis conditioned media. 
It indicated PDGFBB was one of the major factor(s) responsible for promoting 
endothelial cells proliferation. 
~ “ • 
\ 
CHAPTER FOUR DISCUSSION 
Results in invasion assay showed that factor(s) secreted in tendinosis fibroblasts can 
attract migration of human endothelial cells. However, no difference was showed 
using healthy tendon fibroblasts conditioned media when compared with control. The 
angiogenic ability of the factor(s) secreted in tendinosis fibroblasts was not only 
showed in in vitro model, but also in animal model. Results in C A M assay showed 
that factor(s) secreted in tendinosis fibroblasts could enhance new blood vessel 
formation. However, factor(s) secreted in healthy tendon fibroblasts could not 
enhance new blood vessel formation when compared with control. 
4.2.2 Tendinosis Fibroblasts Secrete PDGFBB and Take Effect in Endothelial 
Cells Proliferation 
Both PDGFBB and TGF-P w e r e charac te r ized in t end inos i s cond i t ioned media . 
PDGFbb is an ang iogen ic factor, w h i c h can p r o m o t e ang iogens i s (Nakanish i K et al, 
1997). S ince inhibi t ion assay us ing ant i -POGFoB an t ibod ies could suppress the 
prol i fera t ion of endothel ia l cells induced b y tendinos is condi t ioned media . It 
indicated PDGFbb took act ion in p romot ing endothel ia l cells prol i fera t ion. 
Another cy tok ine w a s also character ized in condi t ioned media . Tendinos is f ibroblas ts 
secretcd m o r e T G F - p i when compared with hea l thy control and it has its b iphasic 
proper ty in angiogenes is . In relation to endothel ia l cells, the informat ion seems to be 
contradictory. It is reported that TGF-fM can inhibit endothel ial ccll prol i fera t ion 
(Fas te r -Schroder et al, 1986) and migrat ion (Baird and Durking , 1986) in vitro. 
However , it has been reported to s t imulate m i c o n essel format ion in vivo (Rober ts et 
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al，1986). TGF-p 1 at low dosage failed to induce angiogenesis but induced 
angiogenesis at high dosage (Fajardo LF et al, 1996). 
The current study demonstrated the possible relationship between hypervascularity in 
tendinosis tissues and abnormal secretion of PDGFBB in tendinosis fibroblasts. Higher 
PDGFBB secretion in tendinosis fibroblasts is likely associated with the 
hypervascularity in tendinosis. 
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4.3 TENDINOSIS FIBROBLASTS SECRETE MORE PROTEOLYTIC 
ENZYMES 
Our result in gelatin zymography showed that tendinosis fibroblasts secreted more 
proteolytic enzyme when compared with healthy control. Since M M P - 1 is a 
collagenase which can degrade for collagen and TIMP-1 is an inhibitor for MMP-1, 
M M P - 1 and TIMP-1 were quantified using ELISA. It showed that tendinosis 
fibroblasts secreted more M M P - 1 when compared with healthy tendon fibroblasts. On 
the other hand, the healthy tendon fibroblasts secrete more TIMP-1 when compared 
with tendinosis fibroblasts. M M P - 1 and TIMP-1 are present in normal healthy 
individuals and have shown to have an important role in processes such as wound 
healing especially in remodeling of extracellular matrix, pregnancy and parturition, 
bone resorption and mammary involution (Parsons SL et al, 1997). Up-regulation of 
M M P - 1 was also observed in many pathological conditions. A number of connective 
tissue disorders (Palombo et al., 1999; Peters et al., 1997), inflammatory diseases 
(Kieseier et al., 1999), as well as neoplasm (Powell et al., 1996), are found to be 
associated with an imbalance of M M P s and TIMPs in favour of enhanced matrix 
degradation. It is thus possible that the pathological changes of balance of M M P - 1 
and TIMP-1, as well as the augmented proteolytic activity in tendinosis favour matrix 
degradation would result in a disrupted extracellular matrix of the tendon for 
tendinosis patients. 
When compared with healthy control, abnormal of M M P - 1 and TIMP-1 
secretion existed in tendinosis fibroblasts. It is possible that tendinosis manifests as a 
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tendon healing disorder. Furthermore, augmentation of M M P - 1 secretion could 
contribute to the disruption of collagen content in tendinosis tissues. Besides, 
hypercellularity was also demonstrated in the clinical samples. The expansion of cell 
population is fibrous tissues may give the signal to the cell for disintegration of 
collagenous matrix to free out more space. Thus increase of proteolytic enzymes to 
degrade the collagen matrix and cause the disruption and disorganized matrix 
structure in tendinosis samples. In the immunochemical study of tendinosis samples 
(Wang W , 2000), threre is an increased percentage of cell synthesizing procollagen 
type I in tendinosis which suggests a tendency to produce collagen in order to 
recuperate the loss in the disrupted collagen matrix (Russell et al 1989). 
M M P s are secreted as inactive zymogens that require activation by proteolytic 
cleavage. M M P s themselves and other proteases, such as plasmin, are known to 
modulate this process. The activated forms are subjected to inhibition by TIMPs, 
which are expressed ubiquitously in the extracellular matrix and form a complex of 
1:1 stoichiometry with endoproteinases (Bemd K et al, 1999). Without activation, 
zymogens are not active, thus, do not have any proteolytic activities to cleavage the 
substrate. For the conditioned medium collected from tendon fibroblasts, was in 
serum free. Only the fibroblasts secreted substance will activate the latent M M P s . 
From the result of gelatin zymography, the proteolytic activities in tendinosis 
conditioned media is much higher than healthy tendon fibroblasts conditioned media. 
It implied that the fibroblasts not only secrete more MMP-1, but also the proteases to 
activate the M M P s . TGFpi can upregulate M M P l (Benson, 1998) expression，and is 
involved in adhesion formation in tendon (Abraham et al., 2000). Since we 
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characterized TGFpi secretion in tendinosis fibroblasts were higher when compared 
with healthy control, higher M M P - 1 secretion in tendinosis fibroblasts is likely related 
to its up-regulated TGFpi secretion. 
Current study is demonstrated the collagen disruption is related to abnormal secretion 
of M M P - 1 and TIMP-1 in tendinosis fibroblasts. Besides, it also demonstrated the 
tendinosis fibroblasts secrete more proteolytic enzyme (MMP-1) when compared 
with healthy control. 
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4.4 PROINFLAMMATORY CHARACTERISTICS IN TENDINOSIS 
FIBROBLASTS 
4.4.1 Up-regulation ofPGE! and COX-2 in Tendinosis Fibroblasts 
The expression of COX-2 and secretion of TGF-P 1 were higher in tendinosis 
fibroblasts as compared with healthy patellar tendon fibroblasts, while the production 
ofPGE2 by tendinosis fibroblasts was also higher than healthy tendon fibroblasts. The 
results implied that elevated levels of PGE�，COX-2 and TGF-P 1 were involved in the 
development of the pathological conditions of patellar tendinosis. 
Since COX-2 is the rate-limiting enzyme for the synthesis of pro-inflammatory 
prostaglandins, when COX-2 increases, the production of pro-inflammatory 
prostaglandins such as PGE2 increase (Seitbet et al., 1997). COX-2 responds quickly 
to inflammatory cytokines, and its expression level is subsided when the 
inflammatory response is resolved (Seitbet et al, 1997). Despite the lack of 
inflammatory signs in tendinosis samples at the time of collection, we still found 
abnormal expression of COX-2 in tendinosis. In patellar tendinosis, inflammatory 
infiltration was not observed but COX-2 expression was high, some stimulatory 
signals for COX-2 induction must be present. Since COX-2 can be induced by 
TGF-P 1 (Vane et al, 1998), we speculated that sustained COX-2 expression in patellar 
tendinosis was associated with increased TGF-pi levels. 
PGE2 is a potent vasodepressor, which increases blood flow to the inflamed site and 
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enhances edema. It lowers the pain threshold by sensitizing the peripheral terminals of 
primary afferent noiciceptor (Vane et al, 1998; Zhang et al, 1997). The reason why the 
patients feel painful is likely associated with the PGE2. Thus it is possible that the 
clinical signs of tendinosis, manifested as swelling and activity-related pain, maybe 
related to the increased production of PGE2. However, since all the tendinosis patients 
in this study have taken non-steriodal anti-inflammatory drugs (NSAIDs) as treatment 
and the conditions were not improved, other mediators for edema and pain maybe 
involved in addition to the elevated prostaglandin production. 
Up-regulation of COX-2 Expression and TGFfil Secretion in Tendinosis 
Fibroblasts 
The elevation of expression level of COX-2 and TGF-pi can be considered as “signs” 
of inflammatory events, but the absence of inflammatory cells in the tendinosis tissues 
put doubts on the existence of inflammation. All tendinosis cases received more than 
six months of non-operative management including physiotherapeutic modalities 
after manifestation of symptoms, and surgical operations were performed when these 
treatments were insufficient, with M R I and ultrasound imaging indicating the 
development of tendinosis. It is thus not certain whether inflammatory responses have 
been involved in early stages of tendinosis, or a normal inflammatory response should 
have died out in the period of non-operative treatment. So we cannot rule out an early 
inflammatory phase or other inflammatory mediators involving in the development of 
patellar tendinosis. 
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The present study may provide a possible explanation since PGE2 and TGF-P 1 also 
possess anti-inflammatory actions. Despite its ability to regulate early inflammatory 
response, TGF-p 1 exerts anti-proliferative activated leukocytes and effectively 
dampens immune and inflammatory pathways (Wahl et al, 1999, Benson, 1998). 
Similarly, PGE2 is a potent inhibitor of neutrophil and monocyte inspite of its 
vaso-regulatory activities (Wu et al, 1996, Zhang et al, 1997). The elevation of 
TGF-P 1 expression and PGE2 production may thus negatively regulate inflammatory 
response. 
Current study is demonstrated the up-regulated expression of COX-2 in tenindosis 
fibroblasts and the abnormal secretion of PGE2 in tendinosis fibroblasts. The results 
implied that elevated level of COX-2 might be involved in the development of the 
pathological conditions of tendinosis and those characteristics were even maintained 
after the cells separated from the tissues. 
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4.5 COMPARISON OF IN VITRO AND HISTOLOGICAL STUDY 
Besides the in vitro tendinosis study, our research group has another team member 
performing the immunohistochemical study in tendinosis tissues (Wang W, 2000). 
The results from in vitro study were compared with the immunohistochemical study. 
Table 4.1 and 4.2 summarize the results in in vitro and immunohistochemical study. 
Proliferating cells were detected by the immunohistochemical staining of 
Proliferation Cell Nuclear Antigen (PCNA), a protein only appearing in proliferating 
cell in human patellar tendinosis tissues in comparison with healthy controls. Image 
analysis was used to semi-qualify the expression of the P C N A in tendinosis tissues. 
Results showed that the P C N A expression in tendinosis tissues was higher than that in 
the healthy tendon fibroblasts. P C N A staining demonstrated a higher proliferative 
index in tendinosis tissues, indicating that the hypercellularity is likely to be caused 
by an increased proliferation. The finding agreed with the result in this in vitro study, 
which the tendinosis fibroblasts have a higher proliferation capacity and more prone 
to stimulation. It indicated that tendinosis fibroblasts maintained the 
hyperproliferative nature in cell culture system and this characteristic was not 
depended on local environmental factors in the tendon. The PDGFp receptor 
expression in tendinosis tissues was also higher than healthy control. This 
characteristic also agreed with the result in immunocytochemical staining of PDGFp 
receptors in tendon fibroblasts. The higher proliferation potential of tendinosis 
fibroblasts is likely associated with the up-regulation of the PDGFp receptors. 
132 
CHAPTER FOUR DISCUSSION 
Immunohistochemical staining of M M P - 1 and T M P - l were used to detect the 
expression of M M P - 1 and T M P - l in tendinosis tissues. The expression of M M P - 1 in 
tendinosis tissues were higher than the healthy control, while the expression of 
TIMP-1 was found to be lower in tendinosis tissues. These results also agreed with the 
study in quantitation of M M P - 1 and TIMP-1 secretion in tendinosis fibroblasts. 
situ gelatin zymography was used to demonstrate the proteolytic. Higher 
proteolytic activity was demonstrated in tendinosis tissues. The proteolytic activity 
mainly resided in the hypercellular areas with cells loosing alignment in tendinosis 
tissue but absent in healthy controls. Similar result was demonstrated in gelatin 
zymography to examine the proteolytic enzymes secreted by tendinosis fibroblasts. 
Expression of TGF-piand COX-2 in tendinosis tissues was higher than healthy 
control. These results also matched with the immunohistochemical staining in 
tendinosis tissues. However, for the PDGFBB expression, tendinosis tissues showed no 
difference with healthy control. On the other hand, the secretion of PDGFBB in 
tendinosis fibroblasts was higher than healthy control. It may related to the 
environmental factors in the tendon affect the expression of PDGFBB in tendinosis 
tissues. 
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4.6 TENDINOSIS FIBROBLASTS SEEMS TO BE TRANSFORMED 
Tendon fibroblast culture is commonly used in the in vitro study of tendon. Current 
study is the first of its kind to characterize the cells derived from tendinosis tissues. 
Studies on tendinosis are limited and up to now, there is no in vitro study in tendinosis. 
The behavior of tendinosis cells in cell culture system is not characterized. W e 
examined whether the characteristics of tendinosis fibroblasts were depended on the 
local environmental factors in tendon. Since cell culture model provides homogenous 
and controllable condition for the fibroblasts, we can study whether the characteristics 
of tendinosis fibroblasts were caused by cell transformation or local environmental 
factors in tendon. 
Fibroblastic characteristic is still observed in cells derived from tendinosis tissues. 
The result from immunocytochemical staining of fibroblasts showed that tendinosis 
fibroblasts still kept its fibroblastic nature and even after the subculture. On the other 
hand, most of the characteristics found in tendinosis samples could still remained in 
tendinosis fibroblasts culture and the tendinosis fibroblasts behave differently when 
compared with healthy control. It implied that the characteristics of tendinosis 
fibroblasts were changed and cells were likely to be transformed. Besides, tendinosis 
fibroblasts secrete more PDGFBB and TGF-p when compared with healthy control. 
Autocrine stimulation is usually found in tumor cells and transformed cells (Steller 
M A et al, 1996). Since tendinosis fibroblasts cannot proliferate under serum free 
condition, we cannot conclude tendinosis fibroblasts are a kind of tumor cells. The 
different response to stimulations thus supported the fibroblasts released from 
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tendinosis tissues behave differently and they are likely to be transformed. 
The expression level of P D G F p receptor and COX-2 were higher in tendinosis 
fibroblasts when compared with the results in immunohistochemical study (human 
speciemens). It is likely related to the selection process in the course of subculture and 
the cells with higher proliferation (tendinosis fibroblasts) can dominate in the culture 
system. 
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4.7 LIMITATION OF THE STUDY 
Although tendinosis is a common pathological condition in tendon diseases, 
inconsistent in the terminology and definition make the clinician mix up with other 
tendon diseases. Besides, patients suffering tendinosis are usually treated with 
NSAIDs and the invasive treatment will be used until the non-invasive treatments are 
failed. As a result, the numbers of tendinosis samples are limited. 
Besides, collection of tendinosis samples are only at one time point, after more than 
six months of the subjective severe symptoms disabling the patients from sports and 
other physical activities. Since we cannot obtain the samples from the patients 
regularly, there are no studies assessing tendinosis tissues over time from early onset 
of symptoms. The onset of symptoms is generally vaguely described by all patients 
with tendinosis, patients could not tell exactly when the initiated episode was and 
what the causes were. Clinically, it is unlikely that a partial rupture of the tendon 
precedes this condition in these patients, since it is most likely to involve a sudden 
onset of pain during activity. As a result, the development of tendinosis and the 
changes of cellular activities at different time points cannot assessed in the present 
study. 
Although the most pathological part of the samples was used for tissues explant 
culture, it is possible that some normal tendon fibroblasts were mixed in the 
tendinosis fibroblasts culture. Since tendinosis fibroblasts have higher proliferation 
potential, tendinosis fibroblasts will dominate in the cell culture system. 
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Cell culture model is used in this study. It can study the growth factors secrete from 
tendinosis fibroblasts and draw the correlation between the abnormal secretion of 
tendinosis fibroblasts and the characteristics of tendinosis. Since the indirect model is 
used in this study, the true contribution of those growth factors to the development of 
tendinosis is still unknown. Furthermore, the contribution of mechanical movement to 
the development of tendinosis cannot be studied in this research. Furthermore, the 
contribution of adjunct structures like tendon sheet cannot be studied in this research. 
As a result, the current study can only provide more background information and 
insight for the study of pathogenesis of tendinosis. 
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Immunohistochemical Staining in vitro Study 
Tendinosis Healthy Tendinosis Healthy 
PCNA High L ^ BrdU H i ^ L ^ 
PDGFpr Hi^ L^ PDGFpr H^ L^ 
MMP-1 High L ^ MMP-1 H i ^ L ^ 
TIMP-1 L^ Hi^ TIMP-1 L^ Hi^^ 
COX-2 Hi^h L^ COX-2 Hi^ L ^ ^ 
TGF-pi High L ^ TGF-pi H i ^ L ^ 
m situ High L w Gelatin High L ^ ^ 
zymography zymography 
Table 4.1 
Table compares the results of parallel study in immunohistochemical study (Wang W, 
MPhil Thesis) and this in vitro study. 
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Immunohistochemical Staining of Tendinosis Tissues 
Tendinosis Healthy 
HSP47 High L ^ 
Expression of Procollagen I N o difference N o difference 
Percentage of Procollagen I High Low 
Immunopositive Cells 
(A) 
in vitro Study of the Fibroblasts Derived from Tendinosis Tissues 
Tendinosis Healthy 
PDGFBB Stimulation High Low 
Proliferation of High Low 
Endothelial Cell 
Invasion Assay High Low 
CAM Assay High Low 
m i h L^ ；^； 
W “ 
Table 4.2 
Tables summarize the results only study in (A) immunohistochemical study (Wang W, 
MPhil Thesis) and (B) in vitro study. 
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CHAPTER 5 FUTURE RESEARCH DIRECTION 
5.1 FURTHER EXPLORATION OF THE FACTORS SECRETED IN 
TENDINOSIS FIBROBLASTS 
5.2 PROTEOGLYCAN SYNTHESIS IN TENDINOSIS FIBROBLASTS 
5.3 TENDINOSIS ANIMAL MODEL AND CLINICAL STUDY 
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5.1 FURTHER EXPLORATION OF THE FACTORS SECRETED IN 
TENDINOSIS FIBROBLASTS 
The current study has demonstrated tendinosis secrete TGF-pi and PDGFBB, which 
may contribute to the hypercellularity, hypervascularity and disrupted extra-cellular 
matrix in tendinosis tissues. However, further exploration of the factors contributing 
those characteristics is needed. Except PDGFBB, other cytokines like basic fibroblast 
growth factor (bFGF) is also a potent mitogenic factor which stimulate the 
proliferation of fibroblasts proliferation and play important role in tendon remodeling. 
Besides, vascular endothelial growth factors (VEGF), platelet derived endothelial cell 
growth factor (PD-ECGF) and bFGF are well known angiogenic factors which can 
induce angiogenesis. The knowledge in the growth factors profile in tendinosis 
fibroblasts will provide useful information to the subsequent etiologic study using 
animal model. Furthermore, the interaction between those factors in contributing of 
tendinosis is also important. 
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5.2 PROTEOGLYCAN SYNTHESIS IN TENDINOSIS FIBROBLASTS 
There is an important characteristic which this study does not encountered is the 
increase in proteoglycan production in tendinosis tissues. Apart form collagen, 
proteoglycans is also an important extra-cellular component in tendon tissue. The 
changes in cellular matrix may associate with the increase in proteoglycans 
production. In soft tissue healing, TGFpi is able to induce proteoglycan synthesis 
(Robbins 1997) and suppress proteoglycan degradation (Mango et al., 1994)， 
resulting in a deposition of proteoglycans but return to normal level afterward. 
However in tendinosis, which is defined as a chronic disorders, proteoglycan content 
still keep in high level at the time of operation. 
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5.3 TENDINOSIS ANIMAL MODEL AND CLINICAL STUDY 
Tendinosis animal model is very important to study the etiology and pathogenesis of 
tendinosis. Continuous efforts in characterizing the pathological condition are same 
important as etiology study in animal model. The current information are only 
sufficient to against the one of the original thinking in the degenerative nature of 
tendinosis. Besides, tendinosis animal model is important for us to find out the 
treatment for tendinosis. Given that we can perform intervention assay in vitro in 
order to evaluate potential therapeutic to "recover" the fibroblasts to perform 
normally, however an animal model is more important to test our hypothesis. Results 
from current study provided PDGFBB and TGF-P 1 may contribute to the altered 
proliferation, hypervascularity and the proteolytic activity of tendinosis comparing 
with healthy control. Therefore, such information can be used in animal model 
establishment. 
The cause of elevated PDGFBB and TGF-p lis still unknown. In animal model, 
different dosage of PDGFBB or TGF-p 1 or combination dosage of PDGFBB and 
TGF-p 1 can be injected into the health patellar tendon. The histological study of 
changes in patellar tendon should be studied in order to observe the change in patellar 
tendon. M R I or U S can be monitor the change of patellar tendon. 
Besides, a clinical study with using the M R I and US to monitor the changes of 
tendinosis condition is also important. As all the samples collected are only in specific 
time point and we cannot identify how long to develop tendinosis in the human tendon. 
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The clinical study which monitoring the changes of tendinosis in human tendon give 
additional information in order to understanding the development of tendinosis. 
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CHAPTER 6 CONCLUSION 
The current study is the first of its kind to characterize the cells derived from 
tendinosis tissues. It mainly focus on the in vitro characterization of tendinosis 
fibroblasts and the growth factors secreted. The cellular activities associate with the 
pathological changes had been investigated which include hypercellularity, 
hypervascularity, matrix disruption and inflammatory response. Healthy patellar 
tendon samples collected from A C L reconstitution were used as control. 
Tendinosis fibroblasts showed higher proliferation when compared with healthy 
control. It is likely related to up-regulation of PDGF-P receptor and the tendinosis 
fibroblasts are more prone to the stimulation. The hypercellularity in tendinosis is 
likely associated with higher proliferation potential of tendinosis fibroblasts. 
In angiogenesis study, tendinosis conditioned media can enhance angiogenesis 
through increase proliferation and attract the migration of endothelial cells as well as 
stimulate blood vessel formation. The results indicate that tendinosis fibroblasts 
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secrete angiogenic factor(s) which stimulate the new blood vessel formation. The 
hypervascularity in tendinosis is likely associated with the angiogenic factor secreted 
in tendinosis fibroblasts. 
Result in gelatin zymography showed tendinosis fibroblasts secrete more proteolytic 
enzyme. It was further quantified by M M P - 1 and TIMP-1 ELISA. Up-regulation of 
M M P - 1 secretion and down-regulation of TIMP-1 secretion were found in tendinosis 
fibroblasts when compared with control. The collagen disruption in tendinosis tissues 
is likely associated with the imbalance of M M P - 1 and TIMP-1 secretion. 
Inflammatory response existed in tendinosis fibroblasts. The result from 
immunocytochemical staining of COX-2, one of the inflammatory mediators, 
showed that the expression of COX-2 was higher in tendinosis fibroblasts. Besides, 
the secretion of PGE2 was also higher in tendinosis fibroblasts. It implied that 
elevated expression of COX-2 was involved in the development of the pathological 
condition of tendinosis. 
TGF-p 1 and PDGFBB were characterized in tendinosis conditioned media. The result 
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showed tendinosis fibroblasts secret more TGF-P 1 and PDGFBB when compared with 
healthy control. These two factors may contribute to the alterations in tendinosis 
fibroblasts. The elevated growth factors secretion might play an important role in the 
pathogenesis of tendinosis fibroblasts. 
In conclusion, the current study has demonstrated that tendinosis fibroblasts behave 
actively as observed in the tissue repairing process, at least at the time of tissue 
sampling. The characteristics of tendinosis can still be maintained in the cell culture 
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Increased cell proliferation and associated 
expression of PDGFRJ5 causing hypercellularity 
in patellar tendinosis 
C. G. Rolf, B. S. C. Fu, A. Pau，W. Wang and B. Chan 
. Department of Orthopaedics and Traumatology, The Chinese University of 
Hong Kong, Shatin, New Territories, Hong Kong 
Abstract 
Objective. This study assessed cellularity in patellar tendinosis with respect to cell proliferation 
and the expression of platelet-derived growth factor receptor ^ (PDGFR^). 
Methods. Surgical samples were taken from 11 patients fulfilling criteria of patellar tendinosis 
and from 12 matched controls. Standard immunohistochemistry methods were used to detect 
expression ofPDGFR/? and proliferation cell nuclear antigen (PCNA). Results were analysed by 
computer-assisted microscopy. Tendon cells were isolated from nine tendinosis and eight control 
tissues for cell culture. 
Results. Increased cellularity {P < 0.001) was observed in tendinosis tissues compared with 
controls, and also a higher proliferative index {P < 0.001). Increased expression o fPDGFR^ was 
demonstrated {P < 0.001). Cultured tendinosis cells showed a higher proliferation rate than 
controls (P < 0.001). This was maintained when the cells were cultured under various conditions 
of serum supplementation (P < 0.01). Tendinosis cells also showed a higher proliferation rate 
(P < 0.01) in medium containing 10 ng/ml PDGF. 
Conclusion. Hypercellularity in patellar tendinosis is caused by increased cell proliferation and 
is associated with increased expression of PDGFR/?. 
KEY WORDS: Tendinosis, Hypercellularity, Patellar tendon, PCNA, PDGF receptor beta. 
Tendinosis is a common chronic tendon disorder with disorganization and loosening of collagen fibrils [2 3 
unknown pathogenesis and causation [1-8]. The clinical 4, 8]. Another obvious alteration is an increase in the 
manifestation is long-standing localized and activity- glycosaminoglycan content of the extracellular matrix 
related pain and swelling, and similar entities are [3, 7’ 8]. 
des^ribec^ in the patellar tendon [9—11], the Achilles Hypercellularity, one of the criteria for tendinosis 
[1:3，4，7] and the ro ta tor cuff of the shoulder putatively resulting f rom the abnormal cellular activity 
]二 巧 e ature is not consistent in the terminology associated with the condition, has not been demon-
ajjd definition of tendinosis. It is sometimes called strated by objective measures. Neither has the activity 
chronic tendinitis, although there is no infiltration of of the 'tendinosis cells' been demonstrated. As some of 
inflammatory cells [2-5]. F rom the aetiological stand- the tendinosis cells appear morphologically different 
pA?nt，i丄endi^sis is often described as an overuse injury f rom tenocytes [3, 7, 8], their origin remains speculative, 
[6] although It occurs in many patients who do not but it is possible that they are transformed tenocytes 
‘ p e r f o r m vigorous physical activity [2]. Some authors Tenocytes normally respond to intrinsic and extrinsic 
regard the disorder as being degenerative [4, 7], although signals upon injury by proliferating and synthes-
tendinosis can also be found in young people [2], It is izing extracellular matrix [12], and by showing some 
. n o t known whether substages of tendinosis exist and morphological changes. However, their role in the 
whether it is an ongoing process or an end-stage. Con- pathogenesis of tendinosis remains unexplored 
sequently, there is no defined and consistent rationale in The purpose of this study was to verify objectively 
c u巧n t methods of management. the presence of hypercellularity and assess cell prolifera-
Histopathological studies of tendinosis tissues tion by analysing the expression of proliferation cell 
characteristically demonstrate hypercellularity, hyper- nuclear antigen (PCNA), a protein that appears only in 
vascularity, lack of inflammatory infiltrates, and proliferating cells [13,14] in human patellar tendinosis 
tissues and not in healthy controls. The relationship 
Submitted 24 February 2000； revised version accepted 18 September between cell proliferation and changes in Cytokine 
2000. responsiveness was further assessed by determination 
Correspondence to： c. G. Rolf. of the expression of platelet-derived growth factor 
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receptor P (PDGFR灼’ as the activation by platelet- were mounted on 3-aminopropyl-triethoxy-silane (Sigma 
derived growth factor _ (PDGFBB) on the PDGFR^^  Chemical, St Louis, MO, USA) and dried overnight at 
is a well-known trigger for fibroblastic cell proliferation 40°C. After removal of paraffin and dehydration, two 
[15]. In order to validate the influence of any alteration consecutive paraffin sections from each sample were 
in PDGFR)5, we also measured the expression level of quenched with 0.5% hydrogen peroxide for 20 min 
PDGFBB- and transferred to 10 mmol/1 citrate buffer solution 
To find out whether the cells retain their pathological (pH 6) and boiled in a microwave oven for 1 min. After 
characteristics in situ, we also prepared tendon cells cooling, the sections were digested with 0.1% trypsin for 
from human tendinosis tissues and compared their 10 min, and incubated with 1% bovine serum albumin in 
proliferative ability with that of healthy tendon cells in phosphate-buffered saline (PBS) for 20 min. Primary 
an established cell culture system. antibody, either a mouse monoclonal anti-human PCNA 
antibody (Oncogene Products, Boston, MA, USA) or a 
Materia ls and me thods ， t m=oclonal anti;hunjan PDGFIY antibody (Santa 
Cruz, CA, USA), at a dilution of 1:100’ was added 
All procedures were approved by the Human Research to the sections, which were kept in a humid chamber 
Ethics Committee of the Chinese University of Hong at 4 � C overnight. After four washes in PBS, the sec-
Kong. tions were incubated for 30 min with secondary anti-
. body [a biotinylated anti-mouse IgG (Dako, Glostrup, 
她ents Denmark) for PCNA and a biotinylated anti-goat 
All subjects and controls were recruited from the IgG (Dako) for PDGFR灼 at a dilution of 1:100. 
Department of Orthopaedics and Traumatology, After three washes in PBS, the sections were incubated 
Prince of Wales Hospital, Hong Kong. Tendinosis and in avidin—biotin complex (Dako kit) for 60 min. The 
control subjects were thoroughly informed about the sections were then exposed for 4 min to a 1% solution 
procedures, and completed consent forms before the of 3,3'-diaminobenzidine tetrahydrochloride for colour 
operation. There were 11 patients (nine males and two development. Finally, the sections were rinsed in dis-
females) with unilateral tendinosis, and their average tilled water, counterstained in Mayer's haematoxylin, 
age was 31 yr (range 15-40). They all had a duration dehydrated through graded alcohol to xylene, and 
of symptoms of more than 6 months and fulfilled mounted in Permount [16]. For better reproducibility 
the clinical and radiological criteria for tendinosis [13， and comparability, all incubation times were strictly 
14]，but were otherwise healthy. They all participated controlled. Control slides were prepared by omitting 
in various recreational sports. They had undergone the primary antibody (negative controls) and histo-
physiotherapy (range 3-8 months) and all had been logical sections (positive controls) with known expres-
treated with oral non-steroidal anti-inflammatory drugs sion of PCNA and PDGFR/?. Immunohistochemical 
(NSAIDs) over shorter periods. None of the patients staining for PDGFBB was also performed according 
had received local cortisone injections. The controls to the same protocol, with a monoclonal anti-
were 12 patients who underwent reconstruction of the human PDGFBB primary antibody (R&D Systems, 
anterior cruciate ligaments, using the patellar tendon as Minneapolis, MN, USA), 
a healthy autograft. These comprised eight males and 
four females with an average age of 31 yr (range 16-38). Semi-quantitative immunohistometry 
None of them reported any history of anterior knee Firstly, all slides were investigated to examine the 
pain. All of these patients had used NSAIDs occasion- quality of brown immunopositive staining for PCNA 
ally and had undergone physiotherapy during a pre- and PDGFR々；the pixel threshold values could be 
operative planning session at least 6 months after the determined by visual inspection. To minimize assess-
injury. They all participated in recreational sports. ment bias, a double-blind design was used. Measure-
Surgery for the tendinosis patients was performed and ments were performed at x 400 magnification. Ten 
guided by clinical findings, including ultrasonography viewing fields (0.038 jim^ each) per slide were sampled 
and/or magnetic resonance imaging. The macroscopic- systematically to avoid allocation bias. Fields of 
ally abnormal region was excised under open vizualiza- view including endothelial cells and synovium cells 
tion, and a piece of tissue measuring 0.5 x 1.5 cm was were skipped and replaced with adjacent fields. Semi-
preserved for analysis. In the control subjects, a piece of quantitative analysis of PCNA and PDGFR/? immuno-
healthy patellar tendon (0.2 x 0.5 cm) was excised from staining was performed with the Leica Q500MC Image 
the remnants of the patellar tendon autograft during Analysis System (Leica, Cambridge, UK). 
anterior cruciate ligament reconstruction. All specimens For immunohistometric measurement, hue-
were cleaned in sterile saline, fixed in buffered formalin saturation-intensity (HSI) colour coding was used for 
and then used to prepare 5-"m thick paraffin-embedded the measurement of mean colour saturation of immuno-
sections. positive cells, which corresponds to the expression level 
Immunohistochemical staining the measured antigen. HSI coding was chosen 
. crniLui、隱““s because it specifies colour by hue, excludes features 
Sections (5 ^m thick) of representative blocks con- that are too light or too dark by intensity, but allows 
taming tendinosis or healthy patellar tendon tissues measurement of the amount of the specified colour by 
「二’.:,::M「： -ir ；；!； • v - .:：.：• ：••- .... ： :: • - .:..:. ：.；： • ： , - . , • V ,.：, •：• .,： „ . . : . . 、：； .： , . . , . — 
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saturat ion. The pixel threshold values (full range 0-255) before being exposed to PDGFBB, and the prolifera-
of immunoposit ive brown colour were recorded as tion rate was measured after 48 h of incubation with 
follows: hue, 128-142; saturat ion, 0-255; intensity, PDGFBB-
22-128. Similarly, the pixel threshold values for brown 
and blue colour, representing the total number of cells, Cell proliferation assay 
were recorded as follows: hue, 30-142; saturation, Cell proliferation rate was measured with a 5-bromo-
0-255; intensity, 22-145. 2 '-deoxyuridine (BrdU) incorporat ion assay kit 
A proliferative index, defined as the number of (Boehringer) [17]. 
PCNA-immunoposi t ive nuclei as a percentage of the 
total number of nuclei, was calculated as the average Immunocytochemical staining of PDGFR^ 
of 10 viewing fields for each section. Similarly, the Tendinosis and healthy tendon fibroblasts were trypsin-
percentage of PDGFR^S-immunopositive cells per field ized and seeded in four-well chamber slides (Nunc) at 
of view and the corresponding immunopositivity were a density of 50 000/well. At confluence, the fibroblasts 
determined. were fixed with 4% paraformaldehyde/phosphate buffer 
for 24 h at 4 � C and quenched with 0.5% hydrogen 
Explant cell culture peroxide for 20 min. The slides were then incubated 
Tendon cells were prepared f rom samples taken f rom with goat monoclonal ant i-human P D G F R ^ pr imary 
nine patients undergoing surgery for patellar tendinosis, ant ibody in a humid chamber at 4°C overnight. The 
and eight age- and gender-matched patients who under- procedures for application of second antibody, colour 
went reconstruction of the anterior cruciate ligaments development and counterstaining were similar to 
using the patellar tendon as a healthy autograf t , adapted the immunohistochemical procedures described above, 
f rom the methods we have used to culture rat tendon Finally, the slides were dehydrated through graded 
fibroblasts [12]. Immediately after surgical removal, the alcohol solutions and mounted with glycerol before 
fresh samples for primary explant culture were rinsed microscopic examination, 
twice with sterilized PBS and once with 1% penicillin- . . 
s t reptomycin-neomycin antibiotic mixture in PBS. The Statistics 
fatty tissues and blood vessels attached to the explants Statistical analysis was performed by SPSS 9.0. As all 
were removed and placed in serum-free Dulbecco's da ta to be tested were found to be normally distributed 
Modified Eagle Medium ( D M E M ) . After the explants by the Kolmogorov-Smirnov test, Student 's t-test was 
had been cut into small pieces ( 1 x 1 mm) under sterile used to compare the proliferative index, the percentage 
conditions, they were placed in t rypsin/EDTA solution of PDGFR^-pos i t ive cells and immunopositivity of 
for 5 min. Ten per cent fetal bovine serum (FBS) in P D G F R j ^ between tendinosis tissue and healthy 
D M E M was used to neutralize the effect of trypsin. The patellar tendon tissue. Two-way analysis of variance 
small explants were placed in 35-mm culture dishes and and the Bonferroni test were employed to compare the 
cultured with 10% F B S / D M E M . After the fibroblasts proliferative responses of tendinosis cells and control 
had migrated f r o m � t h e xplant tissue and reached con- tendon fibroblasts with respect to day of culture, level of 
fluence, the fibroblasts were trypsinized for 3 min at FBS supplementation and PDGFBB supplementation. 
37°C. Trypsin activity was neutralized with 1 ml of 10% Significance was accepted at P < 0.01, in order to 
F B S / D M E M . The trypsinized fibroblasts were centri- compensate for inflated type I error due to multiple 
fuged at 1500-1700 r.p.m. for 5 min, washed with plain tests, 
medium and resuspended in fresh 10% F B S / D M E M . 
Cell density was determined and the cells were seeded p i. 
into a 25 cm^ culture flask at a density of 2 x 10^ cells ^ e s u K S 
per flask. All patellar tendinosis samples exhibited hypercellularity 
„ j.r r 1. . yj , , , and disrupted collagen matrix to various extents, as 
Proliferation of tendinosis cells and healthy tendon revealed by haematoxylin/eosin staining, whereas no 
fibroblasts histological abnormalities were found in the healthy 
Tendinosis cells and healthy tendon fibroblasts f rom the patellar tendon controls, 
culture flask were trypsinized and washed with serum-
free D M E M . The fibroblasts were seeded in 96-well Immunohistochemistry 
microtitre plates at a density of 3000/well in triplicate. Hypercellularity was observed in all patellar tendinosis 
The proliferation rates of cell cultures supplemented samples but in none of the controls. Immunohistochem-
with 10% FBS were measured on days 0, 3, 6, 9，12 ical staining for PCNA, P D G F R ^ and PDGFBB in 
and 15. For the measurement of proliferative responses tendinosis tissue and controls is shown in Fig. 1. The 
at various concentrations of FBS, seeded cells were results of immunohistometric measurements are shown 
exposed to serum-free D M E M for 24 h and then trans- in Table 1. 
ferred to 0, 5, 10 or 20% F B S / D M E M . The proliferation The increase in cell number in tendinosis tissues 
rate was measured at day 6 of culture. To measure was statistically significant {P < 0.001). P C N A staining 
the proliferative response to PDGFBB, seeded cells at demonstrated a higher proliferative index {P < 0.001) in 
a density of 5000/well were starved of FBS for 24 h tendinosis tissues, indicating that the hypercellularity is 
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FIG. 1. PCNA immunostaining of tendinosis patellar tendon (A) and healthy patellar tendon (B), PDGFR{3 immunostaining of 
tendinosis patellar tendon (C) and healthy patellar tendon (D), and PDGF BB immunostaining of tendinosis patellar tendon (E) 
and healthy patellar tendon (F). Tendinosis tissues exhibited increased PCNA and PDGFR{3 expression but no obvious difference 
in PDGF BB expression . Magnification x 600. 
likely to be caused by increased proliferation. Increased 
expression of PDG FR{3 was also clearly shown in both 
the percentage of immunopositive cells (P < 0.001) 
and the immunopositivity for PDGFR{3 (P < 0.001) in 
tendinosis tissue. There were no differences in immuno-
histochemical staining of PDGF BB (Fig. 1 E and F). 
The correlation of the proliferation index with the per-
centage of positive cells and the mean saturation of 
PDGFR{3 immunostain were also statistically significant 
(r = 0.757 and 0.702 respectively, P < 0.001), reflecting 
the association of increased proliferation with increased 
PDGFR{3 expression. 
Cell culture and proliferation assay 
Cultured tendinosis cells had a higher proliferation 
rate than healthy controls (P < 0.01). The higher 
proliferation capacity of tendinosis cells was main-
tained at different concentrations of FBS (P < 0.01). 
:. - ::~ .. ~: .. ~ . ". 
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FIG. 2. PDGFR^ immunostainmg of cultured tendinosis cells (A) and tendon fibroblasts from healthy control tissue (B), showing 
higher expression of PDGFR/? in tendinosis. Magnification x400. 
T A B L E 1. Results of immunohistometry Immunocytochemical Staining for P D G F R ^ showed 
~ that cultured tendinosis cells had a higher expression 
hy patellar . level of PDGFR/? (Fig. 2)，while in the presence of tendon control Tendinosis p, , , T^TAi^ r- ^ „ , f , . , 
= (« = U) 10 ng/ml P D G F tendinosis cells showed a higher 
— proliferation rate (P < 0.01) than healthy control cells 
Cell count per viewing field 9.26 ± 1.2 56.52 ± 6.2* (Table 2). This indicates that the higher proliferative 
tr?义f�ratjon i dex 7.68 ± 1.2 35.45 ± 3.0* capacity of tendinosis cells resulted partly f r o m the 
PDGFR谷-positive cells (%) 23.95 土 4.1 66.88 ± 3.0* higher level of pxnrpwinn nf pnOFT? R PDGFRA immunopositivity 15.62 士 2.5 37.73 土 2.0* 打ig^er level ot expression Ot PDCjFR/；. 
Compared with control samples, tendinosis samples showed an 
increased cell count, a higher proliferation index and greater 
expression of PDGFRjS. DisCUSSion 
Data are mean 士 S.E. 
< 0.01，"test- The present study is the first of its kind to demonstrate 
objectively the hypercellularity associated with increased 
cell proliferation and increased expression of P D G F R ^ 
in human patellar tendinosis. The P C N A staining 
/ unambiguously indicates the presence of a large 
T A B L E 2. Results of proliferation assay in cell culture number of clustering proliferating cells. This indicates 
— — — that tendinosis, at least during the period of sampling, 
Healthy patellar which was more than 6 months after the onset of 
tendon—cftrol Tendmosis subjective symptoms, is an ongoing process, and further 
(" — ) (" 二 9) increase in cellularity can be expected. 
Culture period (days) The tendinosis cells had different shapes and sizes 
0 0.065 士 0.012 0.083 土 0.012* compared with the tenocytes observed in the healthy 
J 0.105 ± 0.041 0.163 ± 0.053 controls. However, they may have originated f rom 
9 溫 0 388 T 0 112* tenocytes, as they also expressed procollagen type I 
12 0:084 士 0 0 5 7 0 106 + 0 0 1 7 * (B. Chan et al., submitted for publication). 
15 0.079 ± 0.010 0:102 J 0:017* Tendinosis is regarded as a chronic condition [2,4, 7], 
FBS supplementation Chronic injury is characterized by slow insidious onset, 
訟 ± 0-0�0 0.044 土 0.005* implying an antecedent subthreshold spectrum of stnic-
10% 0：116± M40 0 I63± ^40* tural damage leading to a crisis episode that is heralded 
20% 0.238 ± 0.065 (1305 ± 0:037 by pain and/or signs of inflammation lasting months to 
P D G F B B (ng/ml) years and distinguished by persistent symptoms without 
0 0.067 ± 0.004 0.074 ± 0.004 resolution [18]. As is clearly shown by this study the  
0.098 ±0.015 0.141 ±0.018* cells are not in a silent end-stage of a degenerative 
Compared with control cells, tendinosis cells showed a higher pro- disorder but are involved in a highly active process. This 
liferation capacity compared with controls during 15 days of culture suggestion is supported by the increased proteoglycan 
with 10% FBS, and the proliferative response was higher with various deposition [2, 3，81. The term 'degeneration' describes 
levels of FBS supplementation. In the presence of 10 ng/ml PDGFbb o ticcn^ frnm q f^r^otor-t^。i c n 
and 2% FBS, tendmosis cells also had ahisher proliferaTion rate after ^ change m a tissue from a greater to a less functionally 
2 days of culture. � active torm, causing cell atrophy and degenerative 
Data are mean 土 S.E. change [18]. Patellar tendinosis cells show opposite 
<0.01. signs, i.e. increased cellular activity. 
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The expansion of the cell populat ion in fibrous tissues 2. Rolf C, Movin T. Etiology, histopathology, and outcome 
requires the disintegration of the collagenous matrix to of surgery in achillodynia. Foot Ankle Int 1997;18:565-9. 
provide free space, as seen f rom the characteristic gross 3. Movin T, Gad A, Reinholt FP, Rolf C. Tendon pathology 
disturbances of the collagen. This raises the possibility 丨“long-standing achillodynia. Biopsy findings in 40 
that tendinosis is rooted partly in alterations in cellular , Orthop Scand 1997义68:170-5. 
activities. It IS thus very likely that any expansion of cell 麵 M Rausmg A. Chronic , Achi les tendmopathy-, -11 L ‘丄 ‘ i；, r r 1 a survey ot surgical and histopathologic findings. Clin number will be at the cost of the fibrous structure of the Orthop 1995-316 151-64 
tendon. The collagen fibres were indeed disrupted and 5. Leadbetter W. Cell matrix response in tendon injury. Clin 
disorganized in all the samples in our study. Sports Med 1992;1 1:533-78. 
Hypercellularity occurs in the early healing phase of 6. Galloway MT, Jokl P, Dayton OW. Achilles tendon 
any tendon injury, when the proliferating tenocytes retain overuse injuries. Clin Sports Med 1992; 11:771-82. 
their fibroblastic appearance and inf lammatory cells are 7. Khan KM, Cook JL, Bonar F, Harcourt P, Astrom M. 
abundan t [12]. The hypercellularity, disturbance of the Histopathology of common tendinopathies. Update and 
collagen matrix and increased proteoglycan content implications for clinical management. Sports Med 1999; 
found in tendinosis is strongly suggestive of a halt in the ^ 27:393-408. 、省。 [ ,1 . • 广 」 * 
early phase of tendon healing, except for the absence of ， : T Kns offerson-Wiberg M, Sha abi A, Gad A 
• fl + ^ , Aspelin P, Rolf C. Intratendinous alterations as imaged 
the inflammatory response. However, we cannot rule by ultrasound and contrast medium enhanced magnetic 
out previous inflammation in the tissues in the present resonance in chronic achillodynia. Foot Ankle 1998; 
study, as the durat ion of symptoms before surgery was 19:311-7. ’ 
more than 6 months . Fur thermore, the absence of 9. Badalamente MA, Sampson SP，Hurst LC et al. The 
inflammatory cells may not rule out other inflammatory pathobiology of stenosing tenosynovitis of the human Al 
mediators. pulley. Trans Orthop Res Soc 1989; 14:199. 
A weakness of this study is that the samples were 1 � . Blazina ME, Kerlan RK, Jobe FW et al. Jumpers knee, 
collected at a single time-point, after more than Orthop Clin N Am 1973;4:665-78. 
6 months of subjective severe symptoms that prevented U . � e r e t t i A, Ippolito E ISjIana二 P et al. Jumpers knee. 
the patients f rom taking part in sports and other . . ^ ？ ? ? ' ^ ^ ， W KK Q T I^ YI：^  1 - 1 . . V • ^ 12. Chan BP, Chan KM, Maffulli N, Webb S, Lee KKH. 
physical activities. For obvious reasons, there are no Effect of basic fibroblastic growth factor—An in vitro 
studies assessing tendinosis tissues over time f rom early study of tendon healing. Clin Orthop Rel Res 1997; 
onset of symptoms. Generally, the onset of symptoms 342:239-4. 
is described vaguely by patients with tendinosis. It is 13. Miyachi K, Fritzler MJ, Tan EM. Autoantibody to 
therefore unlikely that a partial rupture of the tendon a nuclear antigen in proliferating cells. J Immunol 1978; 
preceded the condition in these patients, as this would 121:2228-34. 
probably have involved the sudden onset of pain during 14. Matthews MB, Bernstein RM, Franza R, Garrels JE. 
activity. Identity of the proliferating cell nuclear antigen and cyclin. 
In conclusion, this study shows clearly that the hyper- “ Nature 1984;309:374-6. 
cellularity observed in patellar tendinosis is caused by \ Fima K Vassbotn FS, Beausang-Lmder M 
；r^nroo��乂 r r • ‘ � • ‘ ! _ • J af Ekenstam F, Heldm CH et al. Expression of platelet 
increased ^eH proliferation associated with increased derived growth factor and its receptors in proliferative 
expression ot FUOhK/^. disorders of fibroblastic origin. Am J Pathol 1992; 
140:3:639-48. 
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